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Abstract 
Aim 
The aim of this study was to utilize polarized light microscope for the assessment 
of the efficacy of CPP-ACP, NovaMin and Amine Fluoride pastes on 
remineralization of enamel over time.  
Materials and Methods 
40 teeth were used for the study and were divided into 4 groups with 10 teeth each. 
Remineralization was done by application of CPP-ACP, NovaMin and Amine 
fluoride in the first 3 group’s respectively following demineralization, while the 4th 
group (control) received only demineralization. Teeth were sectioned under hard 
tissue microtome and viewed under polarized light microscope for maximum depth 
of demineralization.  
Results 
Statistical analysis was done using student’s t-test. Mean value of demineralization 
were 78.06μm for CPP-ACP, 156.82μm for Novamin, 109.80μm for Amine 
fluoride and 328.32μm for control group. Although the values were best in CPP-
ACP group, there was no statistical significance difference between CPP-ACP and 
Amine fluoride, and both were better than Novamin.  
  
Conclusion 
The study concluded that CCP-ACP and Amine fluoride were better in 
remineralization followed by NovaMin.       
Keywords 
Demineralization, Remineralization, CPP-ACP, NovaMin, Amine fluoride, 
Polarized light microscopy.  
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INTRODUCTION 
The goal of endodontic therapy is to obtain a fluid tight seal apically and 
coronally. When healing is not achieved after nonsurgical endodontic therapy and when 
retreatment is not possible or has failed, the surgical approach is indicated.       
             The aim of periradicular surgery is to remove the etiologic factor, prevent 
recontamination of the periradicular tissues thereby providing an environment conducive 
to the regeneration of the periodontium that is, healing and regeneration of the alveolar 
bone, periodontal ligament and cementum.  
This procedure includes exposure of the involved apex, resection of apical end of 
root, preparation of class I cavity and insertion of a root end filling material
81
. 
Management of the resected root end during periradicular surgery is critical to a 
successful outcome. The portion of root apex that is inaccessible to instrumentation and 
as a consequence, cannot be cleaned, shaped or filled, or is associated with extraradicular 
infection that is unresponsive to non-surgical treatment, is removed. A filling material is 
then placed into a prepared root-end cavity as a 'physical seal' to prevent the passage of 
microorganisms or their products from the root canal system into the adjacent 
periradicular tissues. The placement of a root-end filling is one of the key steps in 
managing the root end. 
According to Gartner and Dorn, Kim et al. and Chong an ideal root-end filling 
material should adhere or bond to tooth tissue and seal the root end three dimensionally, 
not promote, and preferably inhibit, the growth of pathogenic microorganisms, be 
dimensionally stable and unaffected by moisture in either the set or unset state, be well 
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tolerated by periradicular tissues with no inflammatory reactions, stimulate the 
regeneration of normal periodontium, be non toxic both locally and systemically, not    
corrode or be electrochemically active, not stain the tooth or the periradicular tissues, be 
easily distinguishable on radiographs, have a long shelf life and be easy to handle
10
.                               
 Metals such as gold-foil, silver posts, titanium screws, tin posts, amalgam (with 
and without bonding agent) and gallium alloy are some of the solid, commonly used 
retro-filling materials. Cements and sealers such as ZnOE Cement, IRM, Super EBA, 
Cavit, Zinc Poly carboxylate, Zinc Phosphate and Glass Ionomer Cements, Mineral 
Trioxide Aggregate, Calcium Phosphate Cement and Bone Cement have also been 
employed for retro-fillings. Other commonly used materials are composite resin and 
gutta-percha. The less commonly used materials are laser, ceramic inlay, teflon, mixture 
of powdered dentin & sulfathiazole and cynoacrylates
87
. Unfortunately, the ideal 
retrograde filling material is yet to be found. 
Since the introduction of first Glass-Ionomer Cement (GIC) in the late 1960’s by 
Alan Wilson and Brian Kent, a large number of GIC compositions have been 
investigated, and modifications have been made. 
              GICs are clinically attractive dental materials and have certain unique properties 
that make them useful as restorative and adhesive materials. This includes adhesion to 
moist tooth structure and base metals, anticariogenic property due to the release of 
fluoride, thermal compatibility with tooth enamel, biocompatibility and low toxicity
83
. 
Glass Ionomer exerts antibacterial activity resulting from fluoride release, low pH levels 
when setting, and by the presence of cations such as strontium and zinc
11
. Apart from the 
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well consolidated application in dentistry, these materials, due to their good 
biocompatibility, have been used also for fixation of cochlear implants and as artificial 
bone substitutes for cranial-facial reconstruction
40,69,101
. 
Chitosan (CH), a crystalline polysaccharide is a partially deacetylated derivative 
of chitin. It is the primary structural polymer in arthropod exoskeletons. It is a weak base, 
having at least one primary amino group and two free hydroxyl groups. Chitosan is 
normally insoluble in aqueous solutions above pH 7. However, in dilute acids (pH < 6), 
the free amino groups are protonated and the molecule becomes soluble.
 
The high charge 
density in solution allows chitosan to form insoluble ionic complexes with a wide variety 
of water soluble polyanionic species
80
. Chitosan is biocompatible, hemostatic, accelerates 
the formation of osteoblasts, and has antibacterial and antifungal properties
1,68
. 
 
 Bioactive Glass( BAG), a silica based melt-derived glass developed by Larry 
Hench et al. in 1971, which are generally composed of SiO2, CaO, P2O5 and Na2O. This 
active biomaterial has antimicrobial and anti-inflammatory effects, it has the ability to 
bond to soft and hard tissues; moreover, when implanted in the bone, it displays 
osteoconductive properties which may assist the repair of bony defects
53
. 
Denise F. S. Petri et al.
24
 found that the addition of 10 v/v % of Chitosan led to a 
significant increase in the flexural resistance. Chitosan contents higher than 25 v/v % (50 
v/v% & 100 v/v %) led to poor performance. The amount of fluoride ions released from 
Chitosan, especially from those with 10 v/v % of Chitosan modified GIC was much 
larger than that released from commercial GIC. 
Introduction 
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Helena Yli-Urpo et al.
36determined compressive strength, Young’s modulus of 
elasticity, and Vickers’ surface hardness of conventional cure and resin-modified glass 
ionomer cements after the addition of bioactive glass (BAG) 10-30 wt% and concluded 
that  the addition of BAG to GIC compromises the mechanical properties of the materials 
to some extent.  
Bioactive Glass and Chitosan is mixed with GIC with an  intention that they could 
be  applied as root end  fillings  where their bioactivity could be beneficial and high 
compressive strength is not necessarily needed. 
The purpose of this study is to determine the sealing ability and osteogenic 
potential of  Glass Ionomer Cement on addition of Chitosan(10v/v% and 50 v/v%) and  
Bioactive glass(10wt% and 30 wt %) so that the combination is best used as a root end 
filling material.
 
 
Aim and Objectives 
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AIM AND OBJECTIVES 
Aim 
To evaluate the sealing ability and osteogenic potential of Glass Ionomer Cement 
(Type II) containing Chitosan and Bioactive glass. 
 
Objectives 
 
1. To evaluate the sealing ability of Glass ionomer cement containing 10 v/v % of 
Chitosan, 50 v/v % of Chitosan, Glass ionomer cement containing 10wt% of 
Bioactive glass, 30 wt % of Bioactive glass compared with conventional Glass 
ionomer cement (Type II) by dye penetration method using confocal laser scanning 
microscopy. 
 
2. To evaluate the osteogenic  potential of Glass ionomer cement containing  10 v/v % 
of chitosan, 50 v/v % of Chitosan, Glass ionomer cement containing 10wt% of 
Bioactive glass, 30 wt % of Bioactive glass compared with conventional Glass 
ionomer cement (Type II)   using SaOS-2 cells after culturing and assessing 
 Cell Proliferation using MTT assay after 24 hrs, 48 hrs and 72 hrs. 
 Cell Differentiation by Alkaline Phosphatase activity after 7, 14 and 21 days. 
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REVIEW OF LITERATURE 
SEALING ABILITY 
GLASS IONOMER CEMENT 
Van Riessen AW et al.
 86
 (1990) conducted a  literature study , based on the 
assumption that glass ionomer cement will provide a better sealing and will cause less 
tissue reaction and suggested glass ionomer cement  to be preferred to amalgam when it 
comes to apical sealing properties and tissue reaction. In terms of usability, resorption, 
hardness and costs, no significant differences were found. They concluded that glass 
ionomer cement is an equal or perhaps even better alternative for retrograde amalgam. 
Roth S
 71 
(1991) investigated the use of various glass ionomer cements for 
retrograde root filling from the point of view of sealing qualities, ion release and ease of 
application. The sealing qualities of the material were tested by dye penetration and 
microscopic and SEM examination. They concluded that glass ionomer cement is 
possibly a clinical alternative for the sealing of retrograde cavities; however, the silver-
reinforced materials may cause tissue irritation from release of silver ions and their 
corrosion products. 
Chong BS et al.
17
 (1991) studied the adaptation and sealing ability of a light-
cured glass ionomer cement, conventional glass ionomer cement and amalgam when used 
as a retrograde root filling using a confocal optical microscope with and without a 
fluorescent dye and concluded that the sealing ability of the light-cured glass ionomer 
cement was significantly better than that of amalgam (P < 0.001). The dye penetration 
around the light-cured glass ionomer cement and the conventional glass ionomer cement 
Review of Literature 
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was not significantly different (P > 0.05). However, the sealing ability of the conventional 
glass ionomer cement was significantly better than that of amalgam (P < 0.05). 
Chong BS et al.
18
 (1993) investigated the adaptation and sealing ability of a light-
cured ionomer cement, without a retrograde cavity and compared with the material used 
in a retrograde cavity, and with a conventional glass ionomer cement using a confocal 
optical microscope with a fluorescent dye. They found in the group where the light-cured 
glass ionomer cement was used in a retrograde cavity, the material was often well 
adapted to one cavity wall, but gaps were found on the opposite wall. The light-cured and 
conventional glass ionomer cement retrograde root seals were well adapted to the root 
face, regardless of the thickness of material used and concluded that the thinly applied 
(approximately 1 mm) light-cured glass ionomer cement retrograde root seals permitted 
the least leakage. 
Jesslén P et al.
39
 (1995) analysed total of 67 teeth in 64 patients treated with 
apicectomy and retrograde fillings in a comparative clinical study. They were randomized 
to receive fillings of amalgam or glass ionomer cement. Healing was evaluated clinically 
and radiographically after 1 and 5 years. Evaluation showed no difference in healing 
capacity between the two materials and concluded that glass ionomer cement is a valid 
alternative to amalgam as an apical sealant after apicectomy with equally good long-term 
clinical results. 
Greer BD et al.
31
 (2001) evaluated the apical sealing ability of two compomers 
(Dyract and Geristore), IRM, and Super-EBA using fluid filtration device. The integrity 
of the seal was evaluated for 5 min at 1, 7, 30, and 180 days and concluded that the new 
Review of Literature 
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compomers, Dyract and Geristore are equal or superior to IRM and equivalent to Super-
EBA in their ability to reduce apical leakage when used as retrofilling materials. 
Scheerer SQ et al.
75
 (2001) used Prevotella nigrescens to evaluate the sealing 
ability of Geristore, Super-EBA, and ProRoot when used as root-end filling materials. 
Results after 47 days indicated there were no significant differences between the three 
root-end filling materials against penetration of Prevotella nigrescens. 
De Bruyne MA et al.
23
 (2004) reviewed the basic properties of GICs, such as 
adhesion, antimicrobial effects and biocompatibility, particularly as they relate to use in 
endodontics and concluded that in spite of the critical handling characteristics and the 
inconclusive findings regarding sealing ability and antimicrobial activity, there is 
substantial evidence to confirm their satisfactory clinical performance. Both soft tissue 
and bone compatibility make them suitable for use during endodontic surgery. 
Economides N et al.
26
 (2004) examined  microleakage of two root-end-filling 
materials with and without the use of bonding agents using a fluid transport model at 24 
h, 1 month, and 2 months interval under a low pressure of 0.1 atmosphere. At all 
experimental times, glass-ionomer groups showed significantly less microleakage than 
resins groups. Between Admira and Admira Bond groups, significantly less leakage was 
observed in the root sections with Admira Bond at 24 h. 
CHITOSAN 
Mattioli Belmonte M et al.
52
 (1999) found the chemical association of chitosan 
with inorganic salts, such as calcium phosphate and presented  the physical, chemical and 
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crystallographic characterization of newly-developed cements made of 1) calcium-
phosphate and a chitosan gel obtained by acetic acid treatment, and 2) calcium phosphate 
and a chitosan gel obtained by ascorbic acid treatment. Both cements are self-hardening 
at room temperature and concluded that the cements are promising for application in 
endodontics and restorative dentistry. 
Shin SY et al.
78
 (2005)  evaluated the biocompatibility of chitosan nanofiber 
membranes and examined the effect of the chitosan nanofiber membranes on bone 
regeneration in rabbit calvarial defects.They confirmed that the biocompatibility of the 
chitosan nanofiber membrane with enhanced bone regeneration and no evidence of an 
inflammatory reaction. This experiment showed that chitosan nanofiber membrane may 
be useful as a tool for guided bone regeneration. 
 Wang X et al.
91
 (2006) studied the hemostatic capability, adhesion ability and 
biocompatibility of chitosan sponges and compared with commercial collagen sponges 
and concluded that the chitosan sponge was degraded much slower than the collagen 
sponge, while tissue responses for the chitosan sponges were much greater than for the 
collagen sponges. 
Hayashi Y et al.
34
 (2007) evaluated whether chewing gum containing chitosan, 
can effectively suppress the growth of oral bacteria. The amount of oral bacteria was 
found to significantly decreased in the chitosan group and concluded that a 
supplementation of chitosan to gum is an effective method for controlling the number of 
cariogenic bacteria in situations where it is difficult to brush one's teeth. 
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Denise F.S. Petri et al.
24
 (2007) determined the effect of chitosan on the flexural 
strength and on the release of fluoride ions from glass ionomer restoratives. The study 
used 10 specimens of commercial GIC (Vidrion, SS White) and chitosan modified GIC 
(0.0044, 0.012, 0.025 and 0.045 wt% chitosan) for the flexural strength and 10 specimens 
for the fluoride release. They concluded that the addition of 0.0044 wt% chitosan led to a 
significant increase in the flexural resistance and contents higher than 0.022 wt% led to a 
poor performance and in the presence of chitosan, the release of fluoride ions from glass 
ionomer restoratives was catalyzed. 
Kim IY et al.
43
 (2008) suggested that chitosan and its derivatives are promising 
candidates as a supporting material for tissue engineering applications owing to their 
porous structure, gel forming properties, ease of chemical modification, high affinity to in 
vivo macromolecules and demonstrated the uses of various types of chitosan derivatives 
in various tissue engineering applications namely, skin, bone, cartilage, liver, nerve and 
blood vessel. 
Shin et al.
78
 (2009) evaluated the effect of hydroxyapatite (HA)-chitosan (CS) 
membrane on bone regeneration in the rat calvarial defect. Surgical implantation of the 
HA - CS membrane resulted in enhanced local bone formation at both 2 and 8 weeks 
compared to the control group and suggested that HA-CS membrane would be an 
effective biomaterial for regeneration of periodontal bone. 
Arnaud TM et al.
3
(2010) evaluated the in vitro effect of chitosan  treatment on 
enamel de-remineralization behaviour upon a pH cycling assay using Vickers 
microhardness tester and concluded that Chitosan interferes with the process of 
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demineralization of the tooth enamel inhibiting the release of phosphorus and the 
demineralization is influenced by the concentration and exposure time of the biopolymer 
to the enamel and suggested that chitosan may act as a barrier against acid penetration, 
contributing to its demineralization inhibition. 
Uysal T et al.
84
 (2011)tested the  hypothesis that there is no significant difference 
between the chitosan-containing and conventional nonfluoridated dentifrices in inhibition 
of enamel demineralization around orthodontic brackets and found that  Chitosan-
containing dentifrice showed lower demineralization than the control and they concluded 
that Chitosan-containing dentifrice may reduce the enamel decalcification in patients with 
poor oral hygiene. 
BIOACTIVE GLASS 
Matsuya S et al.
51
 ( 1999) prepared a new glass ionomer cement using bioactive 
glass and investigated its setting process using Fourier Transform Infra Red Spectroscopy 
(FT-IR) and Mass Spectrometry Nuclear Magnetic Reasonance (MAS NMR) analyses 
and suggested that Calcium was released from the glass powder to form carboxylate salt 
and degree of polymerization in the silicate network increased. The setting mechanism of 
the cement was found to be essentially the same as in conventional glass ionomer cement. 
Ana ID et al.
2
 (2003) studied the effects of added bioactive glass on the basic 
setting properties of a commercially available resin-modified glass ionomer cement with 
respect to setting time, mechanical strength, and setting mechanism. It was found to be 
clinically acceptable whether the setting time was extended or shortened depending on 
the type of bioactive glass added. The compressive strength of the set cement containing 
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the bioactive glass decreased and was much higher when compared with the conventional 
type glass ionomer cement containing bioactive glass. The Fourier-transform infrared and 
MAS-NMR spectroscopies revealed that the extent of the acid-base reaction was larger in 
the cements containing bioactive glass than in the commercial resin-modified glass 
ionomer cement because of its high basicity in the bioactive glass. 
Helena Yli-Urpo et al.
35
 (2005)  studied Conventional cure and resin-modified 
light-curing GIC  by adding 10-30 wt% bioactive glass (BAG) using Scanning Electron 
Microscope (SEM), Energy-dispersive X-ray Spectroscopy (EDS) and visual analysis to 
examine the bioactivity and the ability  to mineralize dentin in  intact beagle dog teeth. 
The restorations were followed clinically for 1, 3 or 6 weeks. Resin-modified GIC 
containing BAG showed uniform Calcium Phosphate surface formation on the 
restorations and  concluded that resin-modified GIC containing BAG have good potential 
in clinical applications where enhanced mineralization is expected. 
Helena Yli-Urpo et al.
36
(2005)  determined  compressive strength, Young’s 
modulus of elasticity, and Vickers’ surface hardness  of conventional cure and resin-
modified glass ionomer cements after the addition of bioactive glass (BAG) added in  10-
30 wt% . They found that addition of BAG to GIC compromises the mechanical 
properties of the materials to some extent and concluded that their clinical use ought to be 
restricted to applications where their bioactivity can be beneficial, such as root surface 
fillings and liners in dentistry, and where high compressive strength is not necessarily 
needed. 
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T. Waltimo et al.
89
 (2007) tested the hypothesis that nanometric bioactive glass 
releases more alkaline species, and consequently displays a stronger antimicrobial effect, 
than the currently applied micron-sized material. The shift from micron- to nano-sized 
treatment materials afforded a ten-fold increase in silica release and solution pH elevation 
by more than three units. Furthermore, the killing efficacy was substantially higher with 
the new material against all tested strains. 
Choi  JY et al.
16
 (2008) examined the setting time, diametral tensile strength, and 
in vitro bioactivity of the GIC–Sol gel ( SG) derived Glass with a bioactive composition  
added in 10 and 30 wt %. The setting time of the GIC–SG cements increased with 
increasing amount of SG. However, the addition of SG did not significantly alter the 
diametral tensile strength of the GIC. GIC–SG induced the precipitation of an apatite 
bone-mineral phase on the surface after immersion in a simulated body fluid (SBF), 
showing in vitro bone bioactivity and  confirmed that the GIC– SG samples produced 
higher cell viability than the GIC sample with cell culturing for up to 7 days. 
Xie D et al.
96
 (2008) developed a novel bioactive resin-modified glass-ionomer 
cement system with therapeutic function to dentin capping mineralization. In the system, 
the newly synthesized star-shape poly acrylic acid was formulated with water, Fuji II LC 
filler, and bioactive glass to form resin-modified glass-ionomer cement. Compressive 
strength (CS) and the effect of aging in simulated body fluid (SBF) on CS and 
microhardness of the cements was investigated. The results showed that the system not 
only provided strengths comparable to original commercial Fuji II LC cement but also 
allowed the cement to help mineralize the dentin in the presence of SBF and concluded 
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that this bioactive glass-ionomer cement system has direct therapeutic impact on dental 
restorations that require root surface fillings. 
Mousavinasab SM et al.
57
 ( 2011) compared the flexural strengths (FS) of a 
resin-modified glass-ionomer containing bioactive glass (RMGIBAG) with that of a 
commonly used resin-modified glass-ionomer (RMGI) using three-point bending test at a 
crosshead speed of    0.5 mm/min. and concluded that adding 20 wt% of BAG to the 
RMGI powder decreases FS of the material significantly, while it is still clinically 
acceptable considering the flexural strength values reported for clinically used GIs and 
RMGIs. 
 Huang X et al.
38
 (2012) analysed the antimicrobial activity and physicochemical 
properties of glass ionomer cement and resin-modified glass ionomer cement 
incorporated with chlorhexidine and bioactive glass. They concluded that glass ionomer 
cements incorporated with chlorhexidine can maintain its mechanical properties as well 
as reduce early S. mutans biofilm formation. Controlled release/sustained release 
technology may be required to optimize the antibacterial activity of glass ionomer 
cements incorporated with bioactive glass. 
 
 
 
 
Review of Literature 
 15   
 
OSTEOCONDUCTIVE PROPERTY 
GLASS IONOMER CEMENT 
Zetterqvist L et al.
99
 (1987) investigated the tissue reaction following the use of 
glass-ionomer and amalgam, as retrograde filling materials using 8 monkeys. After 
apicectomy of the upper central incisors, amalgam and glass-ionomer cement was used at 
random as retrograde filling material. 2 animals at a time were sacrificed after 2 weeks, 1, 
3 and 6 months. Irrespective of the length of time, the tissue reactions were similar for the 
2 materials. After 3 and 6 months, there was complete healing with no inflammatory 
reaction and a mature alveolar bone surrounding the apicectomized roots. 
Callis P D and Santini A
12
 (1987) compared tissue healing after apicectomy and 
filling of ferret lower canines with glass ionomer (Ketacfil) or gutta-percha/sealer 
(Tubliseal). Both materials provoked an inflammatory response after 7 days, but the 
response to glass ionomer was less severe. The response after 28 days was different. Mild 
inflammation related to the gutta-percha was still present, but no inflammation was found 
in relation to the glass ionomer. 
 
I.M. Brook et al.
8
 (1991) studied the in vitro response of osteoblast and periosteal 
cells to the component and composite forms of three different glass-ionomer 
(polyalkenoic) cements, comparing them to densely sintered hydroxyapatite and 
tricalcium phosphate ceramics. Qualitative analysis by scanning and transmission 
electron microscopy revealed that osteoblasts colonized all the solid test materials, 
although there was a less favourable response to materials with a rough surface 
topography and to unset and fluoride-containing glasses. A collagen-containing 
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extracellular matrix was elaborated on to the ceramics and set glass-ionomer cements, 
except for one (AquaCem). 
 
Meyer U et al.
54
 (1993) studied the in vitro behaviour of cells on the ionomeric 
bone cement (IC). The cells produced bone matrix proteins (osteocalcin, bone 
sialoprotein II) and were osteoblast-like. The osteoblast-like cells colonized the substrate 
in monolayers and produced an extracellular matrix as seen by light and scanning 
electron microscopy. Morphological comparison between cells growing on the ionomeric 
bone cement and cortical bone revealed no significant difference in phenotypic 
expression. 
 
Oliva A et al.
61
 (1996) compared the response of cultured human osteoblastic 
cells to a number of commercial glass ionomer cements. The GICs tested were: Ketac-Fil 
Aplicap, lonocem lonocap 1.0, GC Fuji II, GC Fuji II LC and Vitremer 3M. The results 
obtained indicated that four of the five glass ionomer cements tested are biocompatible, 
showing vital cells adhering to the materials, proliferating and expressing the biochemical 
markers of osteoblastic phenotype, whereas Vitremer 3M exhibited a great cytotoxicity 
toward the cells. 
 
L.G. Brentegani et al.
7
 (1997) implanted type III glass-ionomer cement (Vidrion 
F), into rat dental alveolus immediately after tooth extraction and its biocompatibility was 
analysed in terms of incorporation into alveolar bone in the wound healing process. 
Quantitative data confirmed progressive new bone formation in parallel with a decrease 
in the percentage fraction of connective tissue in the trial areas around the implants. The 
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results revealed that the tested material is biologically compatible, being progressively 
incorporated into alveolar bone in the wound healing process. 
 
Nikola Buric et al.
59
 (2003) reported the results of experimental use of glass-
ionomer microimplants(GIMIs) in the augmentation of the maxillary alveolar ridge in 
dogs. Histological examination showed that the glass-ionomer microimplants were 
extremely osteoconductive and inert materials. Stimulation of growth of new bone tissue 
in contact with the glassionomer microimplants was evident. No inflammatory cells were 
detected on or adjacent to the GIMIs. 
 
Carlos Alberto de Souza Costa et al.
13
 (2003) evaluated the cytotoxic effects of 
five glass-ionomer cements (GICs) on an odontoblast cell line (MDPC-23). Disks of 
every material were prepared and divided into Group 1: Vitrebond, Group 2: Vitremer, 
Group 3: Fuji II LC, Group 4: Fuji IX GP, Group 5: Ketac-Molar, Group 6: Z-100 
(positive control). In groups 1, 2, 3, 4, and 5, the experimental GICs reduced the cell 
metabolism by 79%, 84%, 54%, 40%, and 42.5%, respectively. Despite the fact that all 
experimental materials were cytotoxic to the MDPC-23 cells, the GICs were the least 
cytotoxic. On the other hand, the RMGICs caused the highest cytophatic effects. 
 
Pedro P.C. Souza et al.
64
 (2006) evaluated the effects of current resin-modified 
glass-ionomer cements (RMGICs) applied on culture of cells or implanted into 
subcutaneous tissue of rats. Rely X Luting Cement (RL), Vitremer (VM), and Vitrebond 
(VB) were placed into wells with 1.1 mL of culture medium (DMEM), and incubated for 
24, 48 and 72 hrs. The extracts from every sample were applied on the MDPC-23 cells. 
The experimental materials were implanted into the dorsal subcutaneous tissue of rats.  
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At 7, 30, and 90 days the animals were killed and the biopsies were processed for 
histological evaluation. The extracts obtained at 24h were less cytotoxic than 48 and 72h 
incubation. VB showed the highest cytotoxic effect while there was no statistical 
difference in the cytotoxic effect of VM and RL for the 24-hour period. All RMGICs 
elicited a moderate to intense inflammatory reaction at 7 days which decreased over time. 
At 90-day evaluation connective healing occurred for most of samples. 
H.J. Chang et al.
14
 (2009) demonstrated concentration of collagen integrated into 
glass ionomer may improve both biocompatibility and the mechanical properties of the 
material. The glass-ionomer/collagen hybrids presented enhanced compressive strength 
when integrated with 0.01% collagen, while higher concentrations of collagen 
compromised their mechanical property. In summary, collagen improved both the 
mechanical and biocompatible properties of glass ionomers. 
 
Delia S Brauer et al.
22
 (2011) created zinc-containing Glass Polyalkeonate 
Cements and characterized their mechanical properties and biocompatibility. Zinc-
containing cements showed adhesion to bone close to 1 MPa, which was significantly 
greater than that of zinc-free cements (<0.05 MPa) and other currently approved 
biological adhesives. Results showed that although low levels of zinc may be beneficial 
to cells, zinc concentrations of 400 μM Zn2+ or more resulted in cell death. 
CHITOSAN 
Ashkan Lahiji et al.
4 
(2000) tested the hypothesis that chitosan promotes the 
survival and function of osteoblasts and chondrocytes. Chitosan was coated onto plastic 
coverslips that had been fitted into 24 well plates. Human osteoblasts and articular 
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chondrocytes were coated on either uncoated or chitosan coated cover slips at 1x 10
5
 cells 
per well.Cultures were incubated at 37
0
C, 5% CO2 for a period of 7 days. Cell viability 
was assessed using a fluorescent molecular probe.Greater than 90% of human osteoblasts 
and chondrocytes propagated on chitosan remained viable. Reverse transcriptase 
polymerase chain reaction and immunochemistry revealed that human osteoblasts 
propagated on chitosan films continued to express collagen type I whereas chondrocytes 
expressed collagen type II and aggrecan. They concluded that chitosan may have 
potential use as a tissue engineering tool for the repair of osseous and chondral defects. 
 Zhang Y et al.
100
 ( 2003) studied the response of Human osteoblast-like MG63 
cells  cultured on the composite scaffolds fabricated with macroporous calcium 
phosphate–chitosan . Cell morphology, total protein content, and expression of classic 
markers for osteoblast differentiation were characterized. They concluded that the 
hydroxyapatite–matrix composite scaffolds might enhance the phenotype expression of 
MG63 cells, in comparison with chitosan–matrix scaffolds. Soluble calcium phosphate 
glasses should be added to the scaffolds to prevent chitosan from fast degradation that 
may affect the differentiation of osteoblast cells. 
Kadriye Tuzlakoglu et al.
42
 (2004) reported on the production of chitosan fibers 
and 3-D fiber meshes for the use as tissue engineering scaffolds. After 14 d of immersion 
in simulated body fluid (SBF), scanning electron microscopy (SEM), energy dispersive 
spectroscopy (EDS), and inductively coupled plasma emission (ICP) spectroscopy 
analysis showed that a bioactive Ca-P layer was formed on the surface of the fibers, 
meaning that they exhibit a bioactive behavior .By means of using short-term MEM 
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extraction test, both fibers and scaffolds were found to be non-cytotoxic to fibroblasts. 
Furthermore, osteoblasts directly cultured over chitosan fiber mesh scaffolds presented 
good morphology and no inhibition of cell proliferation could be observed. 
 
Morales JG et al.
55
 (2009) tested the hypotheses that addition of chitosan 
particles to the media of human bone marrow stromal cell (BMSC) cultures stimulates 
osteogenesis by promoting osteoblastic differentiation and by favoring the release of 
angiogenic factors in vitro. They  demonstrated that chitosan particles alone are not 
sufficient to promote osteoblast differentiation of BMSCs in vitro, and suggest that 
chitosan promotes osteogenesis in vivo through indirect mechanisms and  showed that 
continuous addition of dexamethasone promotes osteoblastic differentiation in vitro 
partly by inhibiting gelatinase activity and by suppressing inflammatory cytokines which 
result in increased cell attachment and cell cycle exit. 
 
Nitra Rakkiettiwong et al.
60 
(2011) investigated the effect of BIO-GIC with 
added TGF-beta1 on pulp cells. BIO-GIC was prepared from GIC (conventional type) 
incorporated with 15% of chitosan and 10% of BSA. TGF- beta1 (100 ng) was added in 
BIO-GIC+TGF-beta1 and GIC+TGF-beta1 groups during each disk specimen (10 mm 
diameter, 1 mm high) preparation. The effect of each specimen on pulp cells was 
investigated by using the Transwell plate technique. Cell proliferation was determined by 
MTT assay at 2 time periods (each period lasting 3 days). Pulp cell differentiation was 
examined by alkaline phosphatase activity and also by cell mineralization, which was 
measured by calculating the area of mineralization with von Kossa staining.They 
concluded that  BIO-GIC could retain the effect of TGF-beta1. 
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Mathews S et al.
50
 (2011) evaluated effects of chitosan-coated tissue culture 
plates at different coating densities on adhesion and osteoblast differentiation processes 
of human mesenchymal stem cells (hMSCs), isolated from adult bone marrow using  
alkaline phosphatase assay, demonstration of presence of calcium and real time PCR.This 
study demonstrated for the first time that chitosan enhanced mineralization by 
upregulating the associated genes. 
 
 Chen Y  et al.
15
 (2012)evaluated the in vitro cell biocompatibility of an in situ 
forming composite consisting of chitosan (CS), nano-hydroxyapatite and collagen 
(nHAC), which has a complex hierarchical structure similar to natural bone using 
MC3T3-E1 mouse calvarial preosteoblasts . Cytotoxicity, cell proliferation, and cell 
expression of osteogenic markers such as alkaline phosphatase (ALP), type 1 collagen 
(COL-1), RUNX-2, and osteocalcin (OCN) were examined by biochemical assay and 
reverse transcription polymerase chain reaction and concluded that  CS/nHAC  scaffolds 
were superior to chitosan-only scaffolds in facilitating osteoblast mineralization to be 
used in bone tissue engineering 
 
BIOACTIVE GLASS 
 
Ugo E.Pazzaglia et al.
82
 (1989) gave the first report of manufacture and 
osteoconductivity of silicate based bioactive glass fibres. 
Xynos I D et al.
97
 (2000) investigated the concept of using bioactive substrates as 
templates for in vitro synthesis of bone tissue for transplantation by assessing the 
osteogenic potential of a melt-derived bioactive glass ceramic (Bioglass 45S5) in vitro. 
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Bioactive glass ceramic and bioinert (plastic) substrates were seeded with human primary 
osteoblasts and evaluated after 2, 6, and 12 days. The study showed that Bioglass 45S5 
has the ability to stimulate the growth and osteogenic differentiation of human primary 
osteoblasts. 
Effah Kaufmann EA et al.
27
 (2000) studied osteoblast response to porous 
bioactive glass substrates following the expression of the classical markers for osteoblast 
differentiation like alkaline phosphatase (AP) activity, as well as the expression of 
mRNA for collagen type I (Coll-1), osteonectin (OSN), osteopontin (OPN), osteocalcin 
(OCN), and bone sialoprotein (BSP). The results confirmed that porous bioactive glass 
substrates are capable of supporting the in vitro growth and maturation of osteoblast-like 
cells. At a porosity of 42% and an average pore size of 80 microns, the substrates 
promote the expression and maintenance of the osteoblastic phenotype. 
Loty C et al. 
49 
(2001) investigated the behavior of fetal rat osteoblasts cultured 
on bioactive glasses with 55 wt% silica content (55S) and on a bioinert glass (60S) used 
either in the form of granules or in the form of disks. Cytoenzymatic localization of 
alkaline phosphatase (ALP) and immunolabeling with bone sialoprotein antibody 
revealed a positive staining for the bone nodules formed in cultures on 55S. The 
interfacial analysis showed a firm bone bonding to the 55S surface through an 
intervening apatite layer, confirmed by the X-ray mappings. All these results indicated 
the importance of the surface composition in supporting differentiation of osteogenic 
cells and the subsequent apposition of bone matrix allowing a strong bond of the 
bioactive materials to bone. 
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S. Hattar et al.
33 
(2005) examined the effects of Bioactive glasses on the 
proliferation and differentiation of the mouse preosteoblastic cell line MC3T3-E1. Cells 
were cultured up to 28 days in contact with three types of granules: Bioglass 45S5 
granules (BG), 45S5 granules coated with enamel matrix proteins (Emdogain), and a less 
reactive glass used as a control (60S). Findings indicated that Bioglass alone or combined 
with Emdogain, have the ability to support the growth of osteoblast-like cells in vitro and 
to promote osteoblast differentiation by stimulating the expression of major phenotypic 
markers. In addition the bioactive granules coated with Emdogain revealed significantly 
higher protein production than the bioactive granules alone at day 20. 
 
 
Venu G. Varanasi et al.
88
 (2011) studied enhanced collagen type 1 and 
osteocalcin expression in human periodontal ligament fibroblasts (hPDLF) when exposed 
to bioactive glass conditioned media that subsequently may promote early mineralized 
tissue development. Differentiating hPDLF cultures showed enhanced expression of 
collagen type 1 (Col1α1, Col1α2), osteocalcin, and alkaline phosphatase gene expression. 
The results indicated the osteogenic potential of bioactive coating glass in periodontal 
bone defect filling applications. 
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MATERIALS AND METHODS 
The following armamentaria and materials were used in this study. 
Preparation of material specimen (Fig.26) 
Glass Beaker 100ml 
Distilled water 
Digital weighing Balance 
Cement mixing pad 
Mixing spatula 
Plastic filling instrument 
Teflon mould 2 mm x 5 mm 
For sealing  ability (Fig. 3-5 & 17) 
60 Maxillary central incisors 
Airotor  hand piece (NSK) 
Micro motor straight handpiece (NSK) 
Diamond disc 
3% sodium hypochlorite (CE Prime Dent Products) 
17% EDTA 
Normal saline 
Disposable syringe and needle (25 Gauge) 
Endobloc (Dentsply) 
# 701 Plain fissure bur 
K files 15-80 (Dentsply) 
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Barbed broaches 15-40 (Dentsply) 
Finger spreaders 15-40 (Dentsply) 
Finger pluggers 15-40(Dentsply) 
Paper points (Dentsply) 
Zincoxide eugenol ( Prevest Denpro) 
Glass Slab 
Stainless steel Spatula 
Plastic filling instrument 
Dental composite Kit( Tetric N Ceram, Ivoclar) 
Nail varnish 
Ultrasonic unit (ProUltra Peizon Booster) 
Ultrasonic retro tips (Satelec) – (S12-90ND) 
Rhodamine B dye 
LSM 510 Meta Confocal Laser Scanning Microscope (Carl Zeiss) 
Auto polymerizing acrylic resin 
Hard tissue Microtome ( Leica  SP 1600) 
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For Cell culture studies (Fig.18-25) 
24 well, 6 well microtiter plates 
SaOS-2 cell line (NCCS, Pune) 
Trypsin EDTA solution 
Dulbecco’s Modified Eagle’s Medium (DMEM) 
Foetal bovine serum (FBS) 
Ascorbic acid 
β-Glycerophosphate 
CO2 Incubator (Galaxy 170 S, New Brunswick) 
MTT dye agent 
Dimethyl sulphoxide (DMSO) 
p- Nitrophenyl phosphate 
Sodium hydroxide 
ELISA reader 
AutoAnalyser 
Laminar air flow chamber 
Inverted phase contrast microscope 
 
MATERIALS USED IN THIS STUDY (Fig.1) 
Glass Ionomer Cement (Fuji II, GC Corporation. Tokyo, Japan) 
Chitosan (Panvo Organics, Tamilnadu, India) 
Bioactive glass (Perioglass, Novabone products. FL, USA) 
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METHODOLOGY 
Preparation of Chitosan modified GIC 
1.8ml of Glacial acetic acid is made upto 100 ml with distilled water in a 100 ml 
standard flask. 20 mg of chitosan was weighed and dissolved in 0.3N acetic acid, and 
made upto 100 ml with the same acetic acid in a 100ml standard flask to get 0.2 mg/ml 
chitosan solution. 0.1ml of 0.2mg / ml of chitosan solution is added to 0.9 ml of 
conventional glass ionomer cement liquid to get 10 v/v% chitosan modified glass 
ionomer cement.100 mg of chitosan was weighed and dissolved in 0.3 N acetic acid, and 
made upto 100 ml with the same acetic acid in a 100 ml standard flask to get 1mg/ml 
chitosan solution. 0.5 ml of 1 mg/ml of chitosan solution is added to 0.5 ml of 
conventional glass ionomer liquid to get 50 v/v% chitosan modified glass ionomer 
cement. 
Preparation of Bioactive glass modified GIC 
Glass ionomer cement containing Bioactive Glass was prepared by addition of   
10 wt % and 30 wt% of Bioactive Glass to the Glass ionomer powder. 
The experimental groups considered were (Fig.2) 
Group I  - Conventional Glass ionomer cement 
Group II  - Glass ionomer cement containing 10 v/v% Chitosan 
Group III - Glass ionomer cement containing  50 v/v% Chitosan 
Group IV   - Glass ionomer cement containing 10 wt% Bioactive Glass 
Group V - Glass ionomer cement containing 30 wt% Bioactive Glass
Materials and Methods 
    
 
EXPERIMENTAL MATERIALS 
 
Fig.1 GIC, Chitosan, Bioactive Glass 
 
 
Fig.2 GIC, GIC+Chitosan (10v/v% & 50 v/v%), GIC+Bioactive glass(10 wt% & 30wt%)  
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SEALING ABILITY 
Sixty freshly extracted human maxillary central incisors with completely formed 
apices and straight canals were collected and stored in normal saline until use. Teeth with 
calcified canals, tortuous canals and root caries were excluded. The teeth were cleaned 
ultrasonically and sectioned at Cemento-enamel junction with a diamond disk, 
standardizing the root lengths to approximately 16 mm (Fig.6). The pulp tissue was 
extirpated with a barbed broach. K- File # 15 was used to confirm canal patency. The 
working length was determined by subtracting 0.5 mm from the length at which # 15 K 
file appeared at the apical foramen and confirmed with the help of radiographs. 
 
Canals were cleaned and shaped using step back technique. 3% sodium 
hypochlorite and 17% EDTA were used as irrigants. All the canals were enlarged upto 
No. 50 K- file (master apical file) at the apical foramen. The specimens were stored in 
normal saline until obturation. Canals were dried using absorbent paper points and master 
cone selection was confirmed with radiographs (Fig.7). Canals were obturated with gutta 
percha by lateral compaction technique. Radiographs were taken to confirm the quality of 
obturation (Fig.8) and the access cavities were sealed with composite resin restorative 
material after 24 hours. The teeth were then stored in saline for 1 week. 
 
Apical root resections were performed on 55 roots by removing 3 mm of each 
apex at 90 degrees to the long axis of the tooth with a # 701 fissure bur in a high-speed 
handpiece with water coolant (Fig.9).  The 3 mm deep retrograde cavity was prepared 
with an ultrasonic tip, powered by an ultrasonic unit (Fig.10). The cavities were irrigated 
with saline and dried (Fig. 11,12). 
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50 specimens were randomly divided into 5 groups of 10 specimens each. The 
experimental materials were manipulated according to the manufacturer’s instructions 
and the  the test materials were condensed into the cavities using P-40 Plugger (Fig.13, 
14). The specimens were stored in moist cotton at room temperature. They were coated 
with three coats of nail varnish except at the apical 1 mm of the resected root, and then 
were allowed to dry (Fig. 15). 
 
Five instrumented roots with retro-preparations received no retrograde filling, and 
these were used as positive controls. Another five roots were instrumented and obturated 
with gutta-percha and sealer without retro preparation; their entire root surfaces were 
covered with two coats of nail polish and were used as negative controls. 
 
All the specimens were suspended in 0.5% Rhodamine B dye for 24 hours 
(Fig.16). Following this, the roots were rinsed for 1 hr under tap water. The teeth were 
mounted in acrylic blocks and split longitudinally with a hard tissue microtome using a 
water coolant (Fig.17). The specimens were examined under confocal laser scanning 
microscope at 10X magnification (Fig. 5) and microleakage associated with different root 
end filling materials were evaluated in millimeters. 
 
 
 
Procedural Flow Chart 
30 
 
PROCEDURAL FLOWCHART FOR ASSESSING SEALING 
ABILITY 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Sixty freshly extracted human maxillary central incisors with 
completely formed apices and straight canals were collected and 
stored in normal saline 
The teeth were cleaned ultrasonically and sectioned at Cemento-
enamel junction with a diamond disk standardizing the root lengths 
to approximately 16 mm. 
 
The pulp tissue was extirpated with a barbed broach. 
 
Canals were enlarged upto No. 50 K- file using step back technique 
& 3% sodium hypochlorite and 17% EDTA as irrigants.  
Canal patency & working length was determined using Kfiles & 
confirmed by radiographs. 
 
The specimens were stored in normal saline until obturation. 
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A  3 mm deep retrograde cavity was prepared  with an ultrasonic 
tip,irrigated & dried .  The teeth were randomly divided into 5 
groups of 10 specimens each & 1 control group with 5 specimens. 
3 mm Apical root resections  at 90 degrees to the long axis of the 
tooth was done with a  # 701 fissure bur in a high-speed handpiece 
with water coolant 
(n=55) 
Canals were dried using absorbent paper points and master cone selection was 
confirmed with radiographs. Canals were obturated with gutta percha by 
lateral compaction technique & access cavities were sealed with composite. 
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The cavities were filled and 
specimens were stored in 
moist cotton at room 
temperature 
Retro-
preparations 
received no 
retrograde filling 
No retro 
preparation 
& No retro 
filling 
Samples were coated with three coats of nail 
varnish except at the apical 1 mm of the 
resected root, and then were allowed to dry. 
 
Entire root 
surfaces were 
covered with two 
coats of nail 
varnish 
All the specimens were suspended in 0.5% Rhodamine B dye for 24 hours. 
Following this, the roots were rinsed for 1 hr under tap water. 
The teeth were mounted in acrylic blocks and split longitudinally with a 
hard tissue microtome using a water coolant. 
The specimens were examined under confocal laser scanning microscope at  
10X magnification and microleakage was evaluated in millimeters. 
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ARMAMENTARIA FOR SEALING ABILITY 
    
Fig. 3 Airotor  hand piece, Micro motor straight handpiece , Diamond disc, 3% sodium 
hypochlorite, 17% EDTA, Normal saline, Endobloc , # 701 Plain fissure bur, K files 
15-80 ,Barbed broaches 15-40 ,Finger spreaders 15-40, Finger pluggers 15-40, 
Zincoxide eugenol, Plastic filling instrument, Dental composite Kit, Nail varnish,  
Rhodamine B dye 
 
 
Fig.4  Ultrasonic Instrument                        Fig.5 Confocal Laser Scanning Microscopy 
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METHODOLOGY FOR SEALING ABILITY-DYE PENETRATION 
TEST USING CONFOCAL LASER SCANNING MICROSCOPY 
 
Fig.6 Specimens of Maxillary central incisors 
 
 
 
          
Fig.7,8 Radiographic picture of  master cone verification and obturation 
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    Fig.9 Root end resection                              Fig.10 Root end cavity preparation 
                               
 
 
 
 
 
 
   Fig.11 Root end Cavity                                Fig.12 Radiographic picture of root end  
                              cavity 
   
 
 
 
 
 
 
    Fig.13 Root end filling                        Fig.14 Radiographic picture of  root end  
     filling 
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Fig. 15      Specimens coated with nail varnish 
 
Fig.16 Specimens stored in Rhodamine B dye 
 
 
 
 
 
 
 
 
Fig.17 Specimen sectioned with microtome 
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OSTEOGENIC POTENTIAL 
Culture reagents 
1. Dulbecco’s Modified Eagle’s Medium (DMEM) (pH 7.4): 10 g of 
DMEM was dissolved in 800 ml of sterile distilled water. To this solution, 
32.5 ml of 7.5% sodium bicarbonate solution was added followed by 
addition of 10 ml penicillin/streptomycin-amphotericin B solution.  The 
pH was adjusted to 7.4.  The final volume was made up to 1 litre with 
distilled water.  Then the medium was sterile filtered (0.22 µm pore size) 
and stored at 4°C. 
2. DMEM with 10% FBS: 10 ml of FBS was made up to100 ml using 
sterile DMEM.  It was stored in a sterile container in cool and aseptic 
condition. 
3. Osteogenic medium (OM): Osteogenic medium was prepared by 
supplementing DMEM with 10% CSS, 10 mM ß-glycerophosphate and 50 
µg/ml ascorbic acid. 
4. Phosphate buffered saline (PBS) ( pH 7.4) 
5. Trypsin-EDTA solution 
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Culture of SaOS-2 cells: 
 SaOS-2 cell line was procured from the National center for cell sciences 
(NCCS), Pune, India (Fig.24, 25). The cells were grown in culture flasks containing 
DMEM supplemented with 10% FBS.  Upon reaching confluence, as observed in the 
inverted phase contrast microscope, the cells were detached using trypsin-EDTA solution 
and used for subculture or treatment. 
Passaging the cells: 
 The medium from the culture flask was aspirated. The flask was rinsed with   
2 ml of phosphate buffered saline (PBS) and aspirated quickly. One ml of trypsin- EDTA 
solution was added to flask and swirled gently to cover the entire area for 10 sec and 
aspirated quickly. Then the flask was incubated at 37C for 10 min. The detached cells 
were then resuspended in 10 ml of 10% FBS – DMEM, gently mixed well by pipetting 
up and down. From the cell suspension, a drop was placed to the edge of the cover slip of 
Neubauer haemocytometer and the drop was let to run under the cover slip by capillary 
action. Then the cells from the E1, E2, E3, E4 and E5 squares were counted under the 
microscope. The number of cells was calculated using the formula:  
No. of cells = No. of cells counted  50,000 
                        = X cells/ml. 
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Preparation of test samples 
 
Round-shaped samples measuring 2mm thick and 5mm in diameter were prepared 
(Fig.26, 27). 
For MTT Assay-9 samples for every experimental material were prepared. 
For Alkaline Phosphatase Assay-9 samples for every experimental material were 
prepared. 
Cell proliferation assessment using MTT assay. 
Reagents 
1. MTT (3-[4,5-dimethylthiazol-2-yl]2,5-diphenyl tetrazolium bromide): MTT was 
dissolved in DMEM at the concentration of 0.5 mg /ml. 
2. Solubilization solution: Dimethylsulfoxide (DMSO) 
3. Phosphate buffered saline (PBS) (pH 7.4) 
Procedure 
The SaOS-2 cells were plated in 24 well plates at a concentration of 3 x 10
4
 
cells/well (Fig. 28).  24 h after plating, cells were washed twice with 100 µl of phosphate 
buffered saline and starved by incubating the cells with 0.1% BSA for 12 h at 37
o 
C in 
CO2 incubator. The test samples were rinsed three times with Phosphate buffered saline 
(PBS) and α-MEM medium & were placed into the wells of 24-well microtiter plates for 
24 and 48 and 72 hrs and incubated at 37º C (Fig. 29). At the end of treatment, the 
medium from control and test material treated cells were discarded and 100 µl of MTT 
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containing DMEM medium was added to each well. The cells were then incubated for 3 
hours. 
The MTT containing medium was then discarded and the cells were washed with 
PBS (200 µl). The crystals were then dissolved by adding 1 ml of DMSO. The colour 
developed is directly proportional to the number of live cells (Fig. 30). The intensity of 
purple colour was immediately measured in an ELISA reader at 545 nm (Fig.22). 
Cell Differentiation assessment using Alkaline Phosphatase assay 
Reagents 
1.     Glycine buffer (pH 10.5, 0.1M) 
2.      p-nitrophenyl phosphate (0.4%) 
3.      Sodium hydroxide (1N) 
2×10
4
 SaOS-2 cells were seeded on test samples under culture conditions in 
osteogenic medium & the level of ALP activity was determined at day 7, 14 and 21(Fig. 
31). The cells were detached from discs using trypsin/EDTA, and centrifuged for 5 min at 
1000 rpm after being washed twice with PBS. Cell lysate was obtained & ALP activity 
was determined by using p-nitrophenyl phosphate as the substrate (Fig. 32). All 
experiments were done in triplicate. Upon dephosphorylated by ALP, p-Nitrophenyl 
phosphate (pNPP) turned yellow and its color change was directly proportional to ALP. 
The reaction was stopped by the addition of 1 N NaOH to reaction mixture.  This 
colorimetric assay was finished by detecting the absorbance at 405 nm (OD value) using 
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auto analyser (Fig. 23). The alkaline phosphatase activity was expressed as                                                                 
μ moles of -nitrophenol formed per min per microgram of protein. 
The alkaline phosphatase activity was calculated using the formula: 
O.D of unknown 
_____________ 
O.D of known 
x Standard 
Concentration 
x 
Time correction   
factor 
x 
     1 
_________ 
g protein 
= μ moles of p-nitrophenol formed per min per g protein. 
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   PROCEDURAL FLOWCHART FOR ASSESSING OSTEOGENIC 
POTENTIAL 
 
 
 
 
 
 
 
 
 
 
 
 
GroupVI-
Control 
 
SaOS-2 cell line were grown in culture flasks containing DMEM 
supplemented with 10% FBS 
 
On reaching confluence, the cells were detached using trypsin-EDTA 
solution and used for subculture 
 
After passaging, the cells were used for treatment with GIC discs. 
The osteogenic potential was assessed 
Cell proliferation 
assessed  using MTT 
assay 
Cell differentiation 
assessed  using 
Alkaline 
Phosphatase (ALP) 
assay 
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MTT ASSAY 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
   
GroupI 
  GIC 
 
 
( n=9) 
 
GroupII  
     GIC  
       + 
10v/v% 
CH 
( n=9) 
 
 
 
GroupIII 
   GIC  
      + 
50v/v% 
CH 
( n=9) 
 
GroupIV 
GIC  
    + 
10wt% 
BAG 
( n=9) 
 
 
GroupV 
  GIC  
     + 
30wt% 
BAG 
( n=9) 
 
24 h after plating, cells were washed twice with 100 µl of PBS and 
starved by incubating the cells with 0.1% BSA for 12 h at 37
o 
C in CO2 
incubator. 
The SaOS-2 cells were plated in 24 well plates at a concentration of  
3 x 10
4
 cells/well. 
 
Round-shaped samples  measuring 2mm thick and 5mm in 
diameter (9 for every experimental material) were prepared. 
Control 
 
 
 
( n=9) 
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The medium was discarded and 100 µl of MTT containing DMEM 
medium was added to each well. The cells were then incubated for 3 
hours. 
The MTT containing medium was then discarded, washed with  
PBS (200 µl)and  the crystals were then dissolved by adding 1 ml of 
DMSO. 
 
 
 
 
 
 
 
The test samples were rinsed three times with (PBS) and α-MEM 
medium &  placed into 24-well  plates for 24, 48  and 72 hrs and 
incubated at 37º C. 
The optical density values were measured in an ELISA reader at 545 nm 
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ALP ASSAY 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
2×10
4
 SaOS-2 cells were seeded on test material discs under culture 
conditions in  osteogenic medium 
 
 
 
 
 
 
 
The cells were detached from discs using trypsin/EDTA, washed with 
PBS & centrifuged for 5 min at 1000 rpm 
 
 
 
 
 
 
 
 
Cell lysate was obtained & ALP activity was determined by using          
p-nitrophenyl phosphate  as the substrate. 
 
 
 
 
 
 
 
The reaction was stopped by the addition of 1 N NaOH to reaction 
mixture. 
 
 
 
 
 
 
 
The absorbance at 405 nm ( OD value)  was measured using 
auto analyser and alkaline phosphatase activity was expressed as μ 
moles of        -nitrophenol / min / μg protein 
                                                                                 
 
 
 
Test material discs were prepared & divided into 5 groups of 9 wells 
each as mentioned for MTT assay 
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ARMAMENTARIA FOR OSTEOGENIC POTENTIAL 
                            
   
 
 
                             
                                                                            
 
 
                              
Fig.19 MTT, ALP Kits 
 
Fig.18 Dulbecco’s Minimal essential 
medium, Foetal Bovine serum, 
Micropipette, Trypsin- EDTA 
    
 
            
 
Fig.20  Laminar air flow 
chamber 
 
Fig.22 ELISA Reader 
 
Fig. 23 Autoanalyser 
 
Fig.21 Inverted phase contrast 
microscope 
 
            
 
Fig.23 Autoanalyser 
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Fig. 24, 25 SaOS-2 Cell Line 
 
 
 
  
                                                                 
           
 
 
 
 
Fig.26, 27 Preparation of discs for cell culture 
 
SaOS-2 
cells 
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Fig. 28 Samples loaded with cells                               Fig.29 Incubated in CO2 Incubator 
 
 
 
 
 
 
Fig.30 Purple formazan formation  
 
ALKALINE PHOSPHATASE ASSAY 
                             
 
Fig.32 Aliquots separated for 
ALP Assay 
 
Fig.31 Samples loaded with cells 
in osteogenic medium 
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SEALING ABILITY 
Table1. Dye Leakage Values in mm. 
Sample 
No. 
Group I 
Group 
II 
Group 
III 
Group 
IV 
Group 
V 
Group 
VI 
Positive 
control 
Group 
VI I 
Negative 
control 
1 2.32 1.08 2.89 1.23 0.97 3 0 
2 1.95 0.89 3.00 0.92 1.20 3 0 
3 2.87 0.98 2.51 0.76 0.82 3 0 
4 2.14 0.76 1.92 1.28 1.24 3 0 
5 1.74 1.22 2.38 1.00 1.20 3 0 
6 1.21 1.34 2.86 1.35 0.77   
7 1.83 0.50 2.67 1.48 1.52   
8 2.35 1.50 2.96 0.72 1.50   
9 1.53 1.13 2.80 1.30 1.29   
10 1.70 1.10 2.92 1.15 1.52   
 
The dye leakage values were analysed using ONE WAY ANOVA and TUKEY HSD 
POST HOC multiple comparisons at 0.05 level significance. 
Table 2. ONEWAY ANOVA FOR SEALING ABILITY 
 
Mean Std. Deviation F Sig. 
GROUP I 1.9640 .47404 
74.40039 0.000 
GROUP II 1.0500 .28721 
GROUP III 2.6910 .33742 
GROUP IV 1.1190 .25766 
GROUP V 1.2030 .27621 
GROUP VI PC 3.0000 .00000 
GROUP VII NC .0000 .00000 
Total 1.5878 .90016 
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Table 3. POST HOC TUKEY HSD TEST FOR SEALING ABILITY 
Multiple Comparisons 
 
(I) 
GROUPS 
(J) 
GROUPS 
Mean 
Difference 
(I-J) 
Std. 
Error 
Sig. 
95% Confidence 
Interval 
 
 
Lower 
Bound 
Upper Bound 
 
 
GROUP I 
GROUP II .91400
* 
.13837 .000 .4900 1.3380 
 
 
GROUP III -.72700* .13837 .000 -1.1510 -.3030 
 
 
GROUP IV .84500* .13837 .000 .4210 1.2690 
 
 
GROUP V .76100* .13837 .000 .3370 1.1850 
 
 
GROUP VI 
PC 
-1.03600* .16947 .000 -1.5553 -.5167 
 
 
GROUP VII 
NC 
1.96400* .16947 .000 1.4447 2.4833 
 
 
GROUP II 
GROUP I -.91400* .13837 .000 -1.3380 -.4900 
 
 
GROUP III -1.64100* .13837 .000 -2.0650 -1.2170 
 
 
GROUP IV -.06900 .13837 .999 -.4930 .3550 
 
 
GROUP V -.15300 .13837 .924 -.5770 .2710 
 
 
GROUP VI 
PC 
-1.95000* .16947 .000 -2.4693 -1.4307 
 
 
GROUP VII 
NC 
1.05000* .16947 .000 .5307 1.5693 
 
 
GROUP 
III 
GROUP I .72700* .13837 .000 .3030 1.1510 
 
 
GROUP II 1.64100* .13837 .000 1.2170 2.0650 
 
 
GROUP IV 1.57200* .13837 .000 1.1480 1.9960 
 
 
GROUP V 1.48800* .13837 .000 1.0640 1.9120 
 
 
GROUP VI 
PC 
-.30900 .16947 .539 -.8283 .2103 
 
 
GROUP VII 
NC 
2.69100* .16947 .000 2.1717 3.2103 
 
 
GROUP 
IV 
GROUP I -.84500* .13837 .000 -1.2690 -.4210 
 
 
GROUP II .06900 .13837 .999 -.3550 .4930 
 
 
GROUP III -1.57200* .13837 .000 -1.9960 -1.1480 
 
 
GROUP V -.08400 .13837 .996 -.5080 .3400 
 
 
GROUP VI 
PC 
-1.88100* .16947 .000 -2.4003 -1.3617 
 
 
GROUP VII 
NC 
1.11900* .16947 .000 .5997 1.6383 
 
 
GROUP V 
GROUP I -.76100* .13837 .000 -1.1850 -.3370 
 
 
GROUP II .15300 .13837 .924 -.2710 .5770 
 
 
GROUP III -1.48800* .13837 .000 -1.9120 -1.0640 
 
 
GROUP IV .08400 .13837 .996 -.3400 .5080 
 
 
GROUP VI -1.79700* .16947 .000 -2.3163 -1.2777 
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PC 
 
GROUP VII 
NC 
1.20300* .16947 .000 .6837 1.7223 
 
 
GROUP 
VI PC 
GROUP I 1.03600* .16947 .000 .5167 1.5553 
 
 
GROUP II 1.95000* .16947 .000 1.4307 2.4693 
 
 
GROUP III .30900 .16947 .539 -.2103 .8283 
 
 
GROUP IV 1.88100* .16947 .000 1.3617 2.4003 
 
 
GROUP V 1.79700* .16947 .000 1.2777 2.3163 
 
 
GROUP VII 
NC 
3.00000* .19568 .000 2.4004 3.5996 
 
 
GROUP 
VII NC 
GROUP I -1.96400* .16947 .000 -2.4833 -1.4447 
 
 
GROUP II -1.05000* .16947 .000 -1.5693 -.5307 
 
 
GROUP III -2.69100* .16947 .000 -3.2103 -2.1717 
 
 
GROUP IV -1.11900* .16947 .000 -1.6383 -.5997 
 
 
GROUP V -1.20300* .16947 .000 -1.7223 -.6837 
 
 
GROUP VI 
PC 
-3.00000
* 
.19568 .000
 
-3.5996 -2.4004 
 * The mean difference is significant at the .05 level. 
 
INTERPRETATION OF RESULTS OF SEALING ABILITY 
 
Analysis of mean values of the sealing ability at 0.05 level significance reveals 
 Positive control showed maximum leakage & negative control showed no 
leakage. 
 There was significant leakage in all groups when compared with Group VII    
( negative control) 
 Group III significantly showed more leakage than Group I and there was no 
significant difference in leakage values between Group III & positive control. 
 Group II, IV, V showed significantly less leakage values than Group I 
(p<0.05). 
 There was no significant difference in leakage values among Group II, IV, and 
Positive control ≥ Group III > Group I > Group V ≥ Group IV ≥ Group 
II > negative control 
Results 
 
 
CONFOCAL IMAGES (10X magnification) 
GROUP I- GIC 
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GROUP II- GIC +10 V/V% CHITOSAN 
 
MINIMAL DYE  LEAKAGE 
GROUP III- GIC +50 V/V% CHITOSAN 
 
MASSIVE  DYE LEAKAGE 
M 
D 
D 
M 
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GROUP IV- GIC+ 10 wt% BIOACTIVE  GLASS 
 
MINIMAL DYE  LEAKAGE 
GROUP V- GIC+ 30 wt% BIOACTIVE  GLASS 
                                      
MINIMAL DYE LEAKAGE 
M 
M 
D 
D 
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GROUP VI –POSITIVE CONTROL 
 
MASSIVE  DYE  LEAKAGE 
GROUP VII-NEGATIVE CONTROL 
 
NO  DYE LEAKAGE 
 
D 
D 
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HISTOGRAM REPRESENTATION OF SEALING ABILITY (GRAPH 1) 
( Group I-Conventional GIC, Group II –GIC + 10 v/v% Chitosan, Group III-GIC + 50 
v/v % Chitosan, Group IV- GIC +10 wt % BAG, Group V- GIC + 30 wt % BAG, Group 
VI-Positve Control, Group VII- Negative control) 
 
Analysis of mean values of the sealing ability at 0.05 level significance reveals 
 
Positive control  ≥ Group III > Group I  > Group V ≥ Group IV  ≥ Group II > 
negative control 
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OSTEOGENIC POTENTIAL 
Table 4. Optical Density values for MTT assay 
 
The optical density values for MTT assay and Alkaline phosphatase activity expressed as 
μ moles of -nitrophenol formed per min per microgram of protein were analysed using 
ONE WAY ANOVA and TUKEY HSD POST HOC multiple comparisons at 0.05 level 
significance. 
GROUPS 24 hrs 48 hrs 72hrs 
I 0.853 0.821 0.751 
 0.791 0.813 0.837 
 0.837 0.856 0.973 
II 2.510 2.791 3.134 
 2.951 3.018 2.835 
 2.862 2.681 2.721 
III 2.816 3.015 3.018 
 2.835 2.860 2.963 
 2.770 2.781 2.799 
IV 1.646 2.093 1.783 
 1.687 1.759 2.333 
 1.759 1.687 2.718 
V 2.768 2.908 3.110 
 2.843 2.704 2.800 
 2.785 3.032 2.834 
Control 1.582 0.878 0.947 
 1.652 0.964 0.846 
 1.497 0.854 0.828 
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Table 5. ONEWAY ANOVA FOR MTT ASSAY 
Duration Groups 
 
Mean 
 
Std. 
Deviation 
F Sig. 
 
 
24 hrs 
 
GROUP I 
 
.82700 
 
.032187 
186.813 .000 
GROUP II 2.77433 .233204 
GROUP III 2.80700 .033422 
GROUP IV 1.69733 .057204 
GROUP V 2.79867 .039323 
CONTROL 1.57700 .077621 
Total 2.08022 .790549 
 
 
48 hrs 
GROUP I .83000 .022869 
143.197 .000 
GROUP II 2.83000 .171852 
GROUP III 2.88533 .119039 
GROUP IV 1.84633 .216632 
GROUP V 2.88133 .165618 
CONTROL .89867 .057839 
Total 2.02861 .932860 
 
 
72  hrs 
GROUP I .85367 .111935 
56.156 .000 
GROUP II 2.89667 .213294 
GROUP III 2.92667 .113931 
GROUP IV 2.27800 .469920 
GROUP V 2.91467 .170016 
CONTROL .87367 .064143 
Total 2.12389 .965627 
 
 
Table 6. POST HOC TUKEY HSD TEST FOR MTT ASSAY 
 
Multiple Comparisons for 24hrs 
(I) Group 
(J) 
Group 
Mean 
Difference 
(I-J) 
Std. 
Error 
Sig. 95% Confidence Interval 
 
    Lower Bound Upper Bound 
Control Group I .750000
* 
.086526 .000 .45937 1.04063 
 Group II -1.197333* .086526 .000 -1.48797 -.90670 
 Group III -1.230000* .086526 .000 -1.52063 -.93937 
 Group IV -.120333 .086526 .732 -.41097 .17030 
 Group V -1.221667* .086526 .000 -1.51230 -.93103 
Group I Control -.750000* .086526 .000 -1.04063 -.45937 
 Group II -1.947333* .086526 .000 -2.23797 -1.65670 
 Group III -1.980000* .086526 .000 -2.27063 -1.68937 
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 Group IV -.870333* .086526 .000 -1.16097 -.57970 
 Group V -1.971667* .086526 .000 -2.26230 -1.68103 
Group II Control 1.197333* .086526 .000 .90670 1.48797 
 Group I 1.947333* .086526 .000 1.65670 2.23797 
 Group III -.032667 .086526 .999 -.32330 .25797 
 Group IV 1.077000* .086526 .000 .78637 1.36763 
 Group V -.024333 .086526 1.000 -.31497 .26630 
Group III Control 1.230000* .086526 .000 .93937 1.52063 
 Group I 1.980000* .086526 .000 1.68937 2.27063 
 Group II .032667 .086526 .999 -.25797 .32330 
 Group IV 1.109667* .086526 .000 .81903 1.40030 
 Group V .008333 .086526 1.000 -.28230 .29897 
Group IV Control .120333 .086526 .732 -.17030 .41097 
 Group I .870333* .086526 .000 .57970 1.16097 
 Group II -1.077000* .086526 .000 -1.36763 -.78637 
 Group III -1.109667* .086526 .000 -1.40030 -.81903 
 Group V -1.101333* .086526 .000 -1.39197 -.81070 
Group V Control 1.221667* .086526 .000 .93103 1.51230 
 Group I 1.971667* .086526 .000 1.68103 2.26230 
 Group II .024333 .086526 1.000 -.26630 .31497 
 Group III -.008333 .086526 1.000 -.29897 .28230 
 Group IV 1.101333* .086526 .000 .81070 1.39197 
* The mean difference is significant at the .05 level. 
 
Table7. POST HOC TUKEY HSD TEST FOR MTT ASSAY 
 
Multiple Comparisons for 48 hrs 
(I) Group (J) Group 
Mean 
Difference 
(I-J) 
Std. 
Error 
Sig. 95% Confidence Interval 
 
    Lower Bound Upper Bound 
Control Group I .068667 .116395 .990 -.32230 .45963 
 Group II -1.931333
* 
.116395 .000 -2.32230 -1.54037 
 Group III -1.986667* .116395 .000 -2.37763 -1.59570 
 Group IV -.947667* .116395 .000 -1.33863 -.55670 
 Group V -1.982667* .116395 .000 -2.37363 -1.59170 
Group I Control -.068667 .116395 .990 -.45963 .32230 
 Group II -2.000000
* 
.116395 .000 -2.39096 -1.60904 
 Group III -2.055333* .116395 .000 -2.44630 -1.66437 
 Group IV -1.016333* .116395 .000 -1.40730 -.62537 
 Group V -2.051333* .116395 .000 -2.44230 -1.66037 
Group II Control 1.931333* .116395 .000 1.54037 2.32230 
 Group I 2.000000* .116395 .000 1.60904 2.39096 
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 Group III -.055333 .116395 .996 -.44630 .33563 
 Group IV .983667* .116395 .000 .59270 1.37463 
 Group V -.051333 .116395 .997 -.44230 .33963 
Group III Control 1.986667* .116395 .000 1.59570 2.37763 
 Group I 2.055333* .116395 .000 1.66437 2.44630 
 Group II .055333 .116395 .996 -.33563 .44630 
 Group IV 1.039000* .116395 .000 .64804 1.42996 
 Group V .004000 .116395 1.000 -.38696 .39496 
Group IV Control .947667* .116395 .000 .55670 1.33863 
 Group I 1.016333* .116395 .000 .62537 1.40730 
 Group II -.983667* .116395 .000 -1.37463 -.59270 
 Group III -1.039000* .116395 .000 -1.42996 -.64804 
 Group V -1.035000* .116395 .000 -1.42596 -.64404 
Group V Control 1.982667* .116395 .000 1.59170 2.37363 
 Group I 2.051333* .116395 .000 1.66037 2.44230 
 Group II .051333 .116395 .997 -.33963 .44230 
 Group III -.004000 .116395 1.000 -.39496 .38696 
 Group IV 1.035000* .116395 .000 .64404 1.42596 
* The mean difference is significant at the .05 level. 
 
Table8. POST HOC TUKEY HSD TEST FOR MTT ASSAY 
 
Multiple Comparisons for 72 hrs 
(I) Group 
(J) 
Group 
Mean 
Difference 
(I-J) 
Std. 
Error 
Sig. 95% Confidence Interval 
 
    Lower Bound Upper Bound 
Control Group I .020000 .189985 1.000 -.61814 .65814 
 Group II -2.023000* .189985 .000 -2.66114 -1.38486 
 Group III -2.053000* .189985 .000 -2.69114 -1.41486 
 Group IV -1.404333* .189985 .000 -2.04248 -.76619 
 Group V -2.041000* .189985 .000 -2.67914 -1.40286 
Group I Control -.020000 .189985 1.000 -.65814 .61814 
 Group II -2.043000* .189985 .000 -2.68114 -1.40486 
 Group III -2.073000* .189985 .000 -2.71114 -1.43486 
 Group IV -1.424333* .189985 .000 -2.06248 -.78619 
 Group V -2.061000* .189985 .000 -2.69914 -1.42286 
Group II Control 2.023000* .189985 .000 1.38486 2.66114 
 Group I 2.043000* .189985 .000 1.40486 2.68114 
 Group III -.030000 .189985 1.000 -.66814 .60814 
 Group IV .618667 .189985 .059 -.01948 1.25681 
 Group V -.018000 .189985 1.000 -.65614 .62014 
Group III Control 2.053000* .189985 .000 1.41486 2.69114 
 Group I 2.073000* .189985 .000 1.43486 2.71114 
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 Group II .030000 .189985 1.000 -.60814 .66814 
 Group IV .648667* .189985 .046 .01052 1.28681 
 Group V .012000 .189985 1.000 -.62614 .65014 
Group IV Control 1.404333* .189985 .000 .76619 2.04248 
 Group I 1.424333* .189985 .000 .78619 2.06248 
 Group II -.618667 .189985 .059 -1.25681 .01948 
 Group III -.648667* .189985 .046 -1.28681 -.01052 
 Group V -.636667 .189985 .051 -1.27481 .00148 
Group V Control 2.041000* .189985 .000 1.40286 2.67914 
 Group I 2.061000* .189985 .000 1.42286 2.69914 
 Group II .018000 .189985 1.000 -.62014 .65614 
 Group III -.012000 .189985 1.000 -.65014 .62614 
 Group IV .636667 .189985 .051 -.00148 1.27481 
*  The mean difference is significant at the .05 level. 
 
 
INTERPRETATION OF RESULTS FOR MTT ASSAY 
Analysis of mean values at 0.05 level significance reveals 
At 24hrs, 48 hrs and 72 hrs 
 Groups II, III, IV,V were significantly greater than Group I (p<0.05). 
 There was no significant difference between Group II, Group III and 
Group V. 
 At 24 & 48 hrs, Group IV was significantly less than Group II, III and V 
(p<0.05)  
At 24 hrs 
 Group I was significantly less than control (p<0.05). 
 There was no significant difference between Group IV and control 
Group III   ≥ Group V ≥ Group II > Group IV ≥ Control >Group I. 
 
At 48 hrs  
 There was no significant difference between Group I and control 
 Group IV was significantly greater than control (p<0.05). 
 
Group III   ≥ Group V ≥ Group II > Group IV > Control  ≥  Group I. 
At 72 hrs 
 There was no significant difference between Group IV,II & V. 
Group III   ≥ Group V ≥ Group II ≥ Group IV > Control  ≥  Group I. 
Results 
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HISTOGRAM REPRESENTATION OF MTT ASSAY ( GRAPH 2) 
( Group I-Conventional GIC, Group II –GIC + 10 v/v% Chitosan, Group III-GIC + 50 
v/v % Chitosan, Group IV- GIC +10 wt % BAG, Group V- GIC + 30 wt % BAG) 
Analysis of mean values at 0.05 level significance reveals 
At 24 hrs 
Group III   ≥ Group V ≥ Group II > Group IV ≥ Control >Group I. 
At 48 hrs 
Group III   ≥ Group V ≥ Group II > Group IV > Control  ≥  Group I. 
At 72 hrs 
Group III   ≥ Group V ≥ Group II ≥ Group IV > Control  ≥  Group I. 
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Table 9. Alkaline phosphatase values expressed as μ moles of -nitrophenol formed 
per min per microgram of protein 
Groups 7 days 14 days 
21days 
 
I 254.4 315.2 394.7 
 241.4 345.3 383.0 
 310.3 295.8 431.1 
II 448.3 534.1 594.1 
 388.6 594.8 580.3 
 493.9 498.5 548.9 
III 449.8 489.2 568.2 
 397.6 544.6 582.0 
 498.4 596.8 598.5 
IV 385.6 556.6 566.2 
 436.8 528.5 589.5 
 445.2 496.1 537.4 
V 431.5 536.5 584.6 
 420.4 533.1 581.2 
 483.1 560.8 564.7 
Control 394.2 493.1 522.3 
 386.5 399.8 451.9 
 398.0 473.2 458.5 
 
Table 10. ONEWAY ANOVA FOR ALKALINE PHOSPHATASE ASSAY 
Duration Groups 
 
Mean 
 
Std. 
Deviation 
F Sig. 
 
 
7 DAYS 
 
GROUP I 
268.700 36.6083 
9.751 .001 GROUP II 443.600 52.8071 
GROUP III 448.600 50.4107 
GROUP IV 422.533 32.2598 
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GROUP V 445.000 33.4591 
CONTROL 392.900 5.8592 
Total 403.556 72.6631 
 
 
14 DAYS 
GROUP I 455.37 49.14 
15.378 .000 
GROUP II 318.77 24.94 
GROUP III 542.47 48.69 
GROUP IV 543.53 53.81 
GROUP V 527.07 30.28 
CONTROL 543.47 15.11 
Total 488.44 90.73 
 
 
21 DAYS 
GROUP I 402.933 25.0847 
26.297 .000 
GROUP II 574.433 23.1641 
GROUP III 582.900 15.1700 
GROUP IV 564.367 26.0983 
GROUP V 576.833 10.6444 
CONTROL 477.567 38.8805 
Total 529.839 72.1643 
 
 
Table11. POST HOC TUKEY HSD TEST FOR ALP 
Multiple Comparisons -7 DAYS 
 
(I) Group 
(J) 
Group 
Mean 
Difference 
(I-J) 
Std. Error Sig. 95% Confidence Interval 
 
    
Lower 
Bound Upper Bound 
Control Group I 124.2000* 31.38388 .018 18.7840 229.6160 
 Group II -50.7000 31.38388 .605 -156.1160 54.7160 
 Group III -55.7000 31.38388 .514 -161.1160 49.7160 
 Group IV -29.6333 31.38388 .927 -135.0493 75.7826 
 Group V -52.1000 31.38388 .579 -157.5160 53.3160 
Group I Control -124.2000* 31.38388 .018 -229.6160 -18.7840 
 Group II -174.9000* 31.38388 .001 -280.3160 -69.4840 
 Group III -179.9000* 31.38388 .001 -285.3160 -74.4840 
 Group IV -153.8333* 31.38388 .004 -259.2493 -48.4174 
 Group V -176.3000* 31.38388 .001 -281.7160 -70.8840 
Group II Control 50.7000 31.38388 .605 -54.7160 156.1160 
 Group I 174.9000* 31.38388 .001 69.4840 280.3160 
 Group III -5.0000 31.38388 1.000 -110.4160 100.4160 
 Group IV 21.0667 31.38388 .982 -84.3493 126.4826 
 Group V -1.4000 31.38388 1.000 -106.8160 104.0160 
Group III Control 55.7000 31.38388 .514 -49.7160 161.1160 
 Group I 179.9000* 31.38388 .001 74.4840 285.3160 
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 Group II 5.0000 31.38388 1.000 -100.4160 110.4160 
 Group IV 26.0667 31.38388 .956 -79.3493 131.4826 
 Group V 3.6000 31.38388 1.000 -101.8160 109.0160 
Group IV Control 29.6333 31.38388 .927 -75.7826 135.0493 
 Group I 153.8333* 31.38388 .004 48.4174 259.2493 
 Group II -21.0667 31.38388 .982 -126.4826 84.3493 
 Group III -26.0667 31.38388 .956 -131.4826 79.3493 
 Group V -22.4667 31.38388 .976 -127.8826 82.9493 
Group V Control 52.1000 31.38388 .579 -53.3160 157.5160 
 Group I 176.3000* 31.38388 .001 70.8840 281.7160 
 Group II 1.4000 31.38388 1.000 -104.0160 106.8160 
 Group III -3.6000 31.38388 1.000 -109.0160 101.8160 
 Group IV 22.4667 31.38388 .976 -82.9493 127.8826 
*  The mean difference is significant at the .05 level. 
 
Table 12. POST HOC TUKEY HSD TEST FOR ALP 
Multiple Comparisons 14 DAYS 
(I) Group (J) Group 
Mean 
Difference 
(I-J) 
Std. 
Error 
Sig. 
95% Confidence 
Interval 
     
Lower 
Bound 
Upper 
Bound 
Control Group I 136.6000* 32.40009 .012 27.7707 245.4293 
 Group II -87.1000 32.40009 .149 -195.9293 21.7293 
 Group III -88.1667 32.40009 .141 -196.9960 20.6627 
 Group IV -71.7000 32.40009 .299 -180.5293 37.1293 
 Group V -88.1000 32.40009 .142 -196.9293 20.7293 
Group I Control -136.6000* 32.40009 .012 -245.4293 -27.7707 
 Group II -223.7000* 32.40009 .000 -332.5293 -114.8707 
 Group III -224.7667* 32.40009 .000 -333.5960 -115.9373 
 Group IV -208.3000* 32.40009 .000 -317.1293 -99.4707 
 Group V -224.7000* 32.40009 .000 -333.5293 -115.8707 
Group II Control 87.1000 32.40009 .149 -21.7293 195.9293 
 Group I 223.7000* 32.40009 .000 114.8707 332.5293 
 Group III -1.0667 32.40009 1.000 -109.8960 107.7627 
 Group IV 15.4000 32.40009 .996 -93.4293 124.2293 
 Group V -1.0000 32.40009 1.000 -109.8293 107.8293 
Group III Control 88.1667 32.40009 .141 -20.6627 196.9960 
 Group I 224.7667* 32.40009 .000 115.9373 333.5960 
 Group II 1.0667 32.40009 1.000 -107.7627 109.8960 
 Group IV 16.4667 32.40009 .995 -92.3627 125.2960 
 Group V .0667 32.40009 1.000 -108.7627 108.8960 
Group IV Control 71.7000 32.40009 .299 -37.1293 180.5293 
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 Group I 208.3000* 32.40009 .000 99.4707 317.1293 
 Group II -15.4000 32.40009 .996 -124.2293 93.4293 
 Group III -16.4667 32.40009 .995 -125.2960 92.3627 
 Group V -16.4000 32.40009 .995 -125.2293 92.4293 
Group V Control 88.1000 32.40009 .142 -20.7293 196.9293 
 Group I 224.7000* 32.40009 .000 115.8707 333.5293 
 Group II 1.0000 32.40009 1.000 -107.8293 109.8293 
 Group III -.0667 32.40009 1.000 -108.8960 108.7627 
 Group IV 16.4000 32.40009 .995 -92.4293 125.2293 
*  The mean difference is significant at the .05 level. 
 
 
Table 13. POST HOC TUKEY HSD TEST FOR ALP 
Multiple Comparisons 21 DAYS 
 
(I) Group (J) Group 
Mean 
Difference 
(I-J) 
Std. 
Error 
Sig. 
95% Confidence 
Interval 
 
    
Lower 
Bound 
Upper 
Bound 
Control Group I 74.6333* 20.28154 .029 6.5093 142.7574 
 Group II -96.8667* 20.28154 .005 -164.9907 -28.7426 
 
Group III 
-
105.3333* 
20.28154 .002 -173.4574 -37.2093 
 Group IV -86.8000* 20.28154 .011 -154.9241 -18.6759 
 Group V -99.2667* 20.28154 .004 -167.3907 -31.1426 
Group I Control -74.6333* 20.28154 .029 -142.7574 -6.5093 
 
Group II 
-
171.5000* 
20.28154 .000 -239.6241 -103.3759 
 
Group III 
-
179.9667* 
20.28154 .000 -248.0907 -111.8426 
 
Group IV 
-
161.4333* 
20.28154 .000 -229.5574 -93.3093 
 
Group V 
-
173.9000* 
20.28154 .000 -242.0241 -105.7759 
Group II Control 96.8667* 20.28154 .005 28.7426 164.9907 
 Group I 171.5000* 20.28154 .000 103.3759 239.6241 
 Group III -8.4667 20.28154 .998 -76.5907 59.6574 
 Group IV 10.0667 20.28154 .995 -58.0574 78.1907 
 Group V -2.4000 20.28154 1.000 -70.5241 65.7241 
Group III Control 105.3333* 20.28154 .002 37.2093 173.4574 
 Group I 179.9667* 20.28154 .000 111.8426 248.0907 
 Group II 8.4667 20.28154 .998 -59.6574 76.5907 
 Group IV 18.5333 20.28154 .936 -49.5907 86.6574 
 Group V 6.0667 20.28154 1.000 -62.0574 74.1907 
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Group IV Control 86.8000* 20.28154 .011 18.6759 154.9241 
 Group I 161.4333* 20.28154 .000 93.3093 229.5574 
 Group II -10.0667 20.28154 .995 -78.1907 58.0574 
 Group III -18.5333 20.28154 .936 -86.6574 49.5907 
 Group V -12.4667 20.28154 .988 -80.5907 55.6574 
Group V Control 99.2667* 20.28154 .004 31.1426 167.3907 
 Group I 173.9000* 20.28154 .000 105.7759 242.0241 
 Group II 2.4000 20.28154 1.000 -65.7241 70.5241 
 Group III -6.0667 20.28154 1.000 -74.1907 62.0574 
 Group IV 12.4667 20.28154 .988 -55.6574 80.5907 
*  The mean difference is significant at the .05 level. 
 
 
INTERPRETATION OF RESULTS FOR ALP ASSAY 
 
At 7days, 14 days and 21 days 
 Group I was significantly less than control (p<0.05). 
 Groups II,III,IV,V were significantly greater than Group I (p<0.05). 
At 7 days and 14 days 
 There was no significant difference between  Control, Group II, Group III,  
Group IV and Group V. 
Group III  ≥ Group V ≥ Group II  ≥ Group IV ≥ Control >Group I. 
At 21 days 
 There was no significant difference between   Group II, Group III, Group 
IV and Group V. 
 Group II, Group III,  Group IV and Group V significantly greater than 
control (p<0.05). 
Group III   ≥ Group V ≥ Group II ≥ Group IV > Control > Group I 
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HISTOGRAM REPRESENTATION OF ALP ASSAY ( GRAPH 3) 
( Group I-Conventional GIC, Group II –GIC + 10 v/v% Chitosan, Group III-GIC + 50 
v/v % Chitosan, Group IV- GIC +10 wt % BAG, Group V- GIC + 30 wt % BAG) 
 
Analysis of mean values at 0.05 level significance reveals 
 
At 7 days and 14 days 
Group III  ≥ Group V ≥ Group II  ≥ Group IV ≥ Control >Group I. 
At 21 days 
Group III   ≥ Group V ≥ Group II ≥ Group IV > Control > Group I
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DISCUSSION 
Periradicular surgery involves surgical debridement of pathological periradicular 
tissue, apical root-end resection, root-end cavity preparation and the placement of a root-
end filling in an attempt to seal the root canal. The ideal healing response after 
periradicular surgery is the re-establishment of an apical attachment apparatus and 
osseous repair.
19 
 
The basic properties of GICs, such as adhesion, antimicrobial effects, ease of 
application and biocompatibility make them suitable for use during endodontic surgery. 
A number of in vitro and in vivo studies have compared GIC with Amalgam, EBA, MTA 
to be used as root end filling material
18,39,72,76
. It would definitely be an advantage if glass 
ionomer cement could possess bioactivity
 
because currently, there is a trend for the 
development of biomaterials that have therapeutic or biologic functions in addition to 
their inherent properties. 
 
Chitosan(CH) is a biocompatible, natural biopolymer that is a copolymer of 
glucosamine and N-acetylglucosamine derived from chitin. Chitosan nanoparticle has 
antibacterial property, which has been suggested for root canal disinfection 
44
. Studies are 
being carried out considering the importance of the biomaterials containing either CH or 
CH derivatives for the regeneration of damaged bone, cartilage, and nerve tissue
30
. 
 
Denise F.S.Petri et al.
24 
(2007) found that CH chains carry many hydroxyl 
groups and acetamide groups, which are able to bind to the hydroxyl groups and to 
Polyacrylic acid carboxylic groups of GIC by hydrogen bonding. The addition of           
10 v/v% CH led to a significant increase in the flexural resistance and contents higher 
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than 25v/v% (50v/v% & 100v/v%) led to a poor performance and in the presence of 
chitosan, the release of fluoride ions from glass ionomer restoratives was catalyzed. 
 
Bioactive glasses (BAG) are surface-active glasses with which bone minerals are 
able to bond chemically. The bioactive nature of BAG and glass-ceramics is related to 
their ability to form a bone-like apatite layer on their surfaces in the body 
environment
37
.Waltimo et al. 
89 
showed that BAG nanoparticulate 45S5 was able to kill 
99% of E.faecalis when incubated in simulated body fluid for 100 minutes. 
 
Matsuya S et al. 
51
( 1999) prepared a new glass ionomer cement using bioactive 
glass and investigated its setting process using Fourier Transform Infra Red Spectroscopy 
(FT-IR) and Mass Spectrometry Nuclear Magnetic Resonance(MAS NMR) and found 
that the setting mechanism of the cement was essentially the same as in conventional 
glass ionomer cement. Helena Yli-Urpo et al.
36
 (2005) found that addition of BAG to 
GIC compromises the mechanical properties of the materials to some extent when added 
in proportions of 10-30 wt %. 
 
Hench et al.
37
( 1972) 
 defined bioactive material as “one that elicits a specific 
biological response at the interface of the material that results in the formation of a bond 
between the tissues and the material”. 
 
This study attempted to enrich GIC with bioactivity by addition of CH and BAG. 
Earlier studies analysed the mechanical  properties on modifying GIC with Chitosan and 
Bioactive glass. This study is the first  attempt to analyse the sealing ability and 
osteogenic potential to be used as a root end filling material. A comparative analysis of 
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the above mentioned properties  by addition of 10v/v% and 50v/v% of chitosan  and 
10wt% and 30 wt% bioactive glass ( concentrations as suggested by earlier studies ) to 
conventional Glass ionomer cement was made. 
 
SEALING ABILITY 
Fluorescent dye is one of the dyes used for microleakage test. D'Alpino et 
al.
21
(2006) stated that fluorescent dyes are useful as tracers because they are detectable in 
dilute concentrations, inexpensive, and non-toxic, allowing use in clinical as well as 
laboratory investigations . Rhodamine B fluoresces when excited by red light of a 
particular wavelength (546 nm).
41 
 
Watson (1997) 
94
 stated that that microleakage studies performed with fluorescent 
dyes and examined using confocal microscopy may provide a more accurate description 
of restorative failure. Earlier studies that used fluorescing agents did not use confocal 
microscopy to test for microleakage. Instead, normal, low-resolution optical microscopy 
was used.  
 
As shown by previous studies, the use of confocal laser scanning microscope 
(CLSM) has shown to be a simple method to test the adaptation of dental materials to the                       
dentin 
62,65,92,93,94
. The use of non-decalcified or hard tissue samples that does not require 
a specific section technique is a clear advantage of confocal analysis 
92
. In spite SEM 
being used extensively for analysis of dental material interfaces, the preparation of the 
specimens, as the sputter-coating procedure, may increase the possibility of artifacts. 
CLSM has added advantage of the ability to control depth of field, elimination or 
reduction of background information away from the focal plane, capability to collect 
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serial optical sections from thick specimens with significant improvement in resolution 
and the microleakage testing rely on the fluorescence criteria of the dye rather than the 
color.  
 For all these reasons a dye leakage study using 0.5% Rhodamine B dye using 
Confocal Laser Scanning microscopy was utilized to detect microleakage in this study. 
 
A controversial topic in the literature is the moment at which the specimens 
should be immersed in the dye solution
66
. In the present study immediate immersion in 
dye by passive dye penetration technique at 37 
0 
C and 100% humidity for 24 hrs was 
selected based on the fact that in clinical situation the root end filling material will be in 
contact with secretions like blood, soon after the insertion in the cavities. 
 
Apical ramifications and lateral canals are very common near the root tip and the 
preferred depth of root resection is 3mm
74
. Root resection at the depth of 3mm reduces 
apical ramifications by 98% and lateral canals by 93%. 
 
Apical root resections  at 90
o
 to the long axis of the tooth has been approved to be 
most acceptable by earlier studies. The inclined plane sectioning at 30
o
 or 40
o
 could have 
disadvantages like open dentinal tubules, errors in post operative radiographs, more 
mechanical stress and loss of dentin, cementum and bone could result in compromised 
healing
74
. The plane of sectioning also affects the degree of microleakage, so a root 
resection angle of 90
0
 was selected for this study. 
 
Plain fissure burs, both high- and low speed, produced the smoothest resected root 
surface, with, plain fissure burs and a low-speed handpiece resulting in the least gutta-
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percha distortion
58
. In this study root end resection was done with #701 fissure bur in a 
high-speed hand piece and water coolant. 
 
Ultrasonic root-end cavity instrumentation produces conservative, smooth, nearly 
parallel walled preparations that followed the direction of root canal more closely and 
have been reported to be contaminated with less debris and smear layer than those 
prepared using a bur 
32,95,45,28
. A success rate of 92.4% was reported in a study that 
evaluated the success/ failure rate of periradicular surgeries performed on 157 teeth 
involving root-end cavity preparations using ultrasonic instrumentation and was 
concluded that ultrasonic root-end preparation provides excellent clinical results
79
. In this 
study, root end cavity of 3mm depth was prepared with S12-90ND ultrasonic tip under 
medium power settings as recommended by the manufacturer. 
 
The results showed that the positive control samples showed dye leakage 
throughout the length of the canals, while the negative control samples had no dye 
penetration. 
 
There was significant leakage in all groups when compared with Group VII 
(negative control) (p<0.05). Group II (GIC +10 v/v% CS), Group IV (GIC +10 wt% 
BAG), GroupV (GIC+30 wt% BAG) showed less linear dye penetration when compared 
with  Group I ( Conventional GIC) which was statistically significant (p<0.05). But there 
was no significant difference in leakage among Group II, Group IV and Group V. 
 
Group III (GIC +50 v/v% CH) significantly showed more leakage than Group I 
(Conventional GIC).This was in accordance with the study done by                         
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Denise F.S.Petri et al.
24
 (2007)
 
who found that the addition of 10 v/v% of CH led to a 
significant increase in the flexural resistance and CH contents higher than 25v/v% (50 
v/v% & 100 v/v%) led to poor performance. This effect can be explained considering that 
some CH chains segregate, interacting with each other, and no longer with Polyacrylic 
acid ( PAA) or the particle surface. So a 50 v/v % CH addition to GIC could have 
considerably affected the original sealing ability of GIC resulting in more leakage.  
 
Group II (GIC +10 v/v% CH) showed less leakage than Group I ( Conventional 
GIC).The probable reason could be increased crosslinking network  formed by CH and 
Polyacrylic acid around the inorganic particles that might reduce the interfacial tension 
among the GIC components, improving mechanical performance
24
. 
 
Also this study showed decreased linear dye penetration in                                          
Group IV (GIC+10wt% BAG) and GroupV (GIC+30wt% BAG) than Group I 
(Conventional GIC). This was not in accordance with earlier studies
36,67
 which stated that 
addition of BAG to GIC decreases the compressive strength (CS), modulus of elasticity 
and surface microhardness because the BAG particles might be only loosely attached to 
the GIC matrix and BAG particles probably acted as fillers that had not been adhered into 
the matrix of GIC leading to decreased CS and modulus of elasticity. 
 
Matsuya et al.
51
 (1999) stated that calcium was released from the bioactive glass 
to form carboxylate salt and the degree of polymerization in the silicate network 
increased. This could be the reason for improved sealing ability with BAG (10 wt % and  
30 wt %) modified GIC  obtained in our study. 
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OSTEOGENIC POTENTIAL 
 
Osteogenic potential can be evaluated by invivo or invitro tests. An in vitro 
comparison using human osteoblasts could elicit more consistent, clear results and allow 
more detailed information than in vivo experiments
98
. In this study, therefore, we 
evaluated the cell proliferation and differentiation using human osteoblasts on the surface 
of set GIC samples. 
 
SaOS-2 cell line was selected as they are characterized by their homogeneity, 
unlimited number of cells, cytokine and growth factor expression profile similar to 
human osteoblast cells, sensitivity to hormonal administration, matrix mineralization, no 
interspecies difference
20
. 
 
MTT ASSAY 
              Cell proliferation was assessed using MTT assay. The MTT assay is dependent 
on the intact activity of the mitochondrial enzyme, succinate dehydrogenase, which is 
impaired after exposure of cells to toxic surroundings. The test involves the conversion of 
a tetrazolium salt 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide to an 
insoluble formazan product, which can be quantified by UV spectrophotometry
56
.To 
assess immediate and late toxic effects of the test materials on cell viability the MTT 
assay was carried out at 24hrs, 48hrs and 72hrs. 
 
               The results showed increased proliferative activity than control in all groups 
except Group I (Conventional GIC) at the end of 24 hrs. After 48 hrs & 72 hrs, Group I 
was not significantly different from control. This was in accordance with many previous 
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in vitro evaluations of GIC biocompatibility.
9,25,73 
. This could be explained by the fact 
that the in vitro toxicity of GICs was due to a complex mechanism based on both ion 
release in particular, Aluminium and Fluoride ions and pH effects. Devlin et al. 
25
(1998) 
stated that aluminum ions contributed to the in vitro toxicity of Ionomeric cements.  
Oliva et al.
61
 (1996) stated the polyacid component (e-g. acrylic, maleic, tartaric and 
benzoic acids) can also create a decreased pH in the immediate environment, further 
contributing to a cytotoxic response. There was statistically significant increase in 
proliferative activity in Group II, III, IV and V than Group I (Conventional GIC) at 24, 
48 & 72 hrs (p<0.05). GROUP II (GIC + 10 v/v% CH), Group III (GIC +50v/v% CH) 
and Group V (GIC + 30wt % BAG) showed higher proliferative activity than all groups 
with no significant difference between them. 
 
               The increased cell proliferative activity in GROUP II (GIC + 10 v/v% CH), 
Group III (GIC +50v/v% CH) was in accordance with the following studies.                 
Shi SF et al.
77
 (2012) showed Chitosan-coated iron oxide nanoparticles enhanced 
osteoblast proliferation, decreased cell membrane damage, and promoted cell 
differentiation, as indicated by an increase in alkaline phosphatase and extracellular 
calcium deposition. Pawlowska E et al.
63 
(2010)   showed that chitosan can reduce the 
percentages of DNA damage caused by 2-hydroxyethyl methacrylate.             
Limapornvanich A et al.
47 
(2009) discovered a novel chitosan - fluoroaluminosilicate 
GIC that can prolong the release of Bovine serum Albumin (BSA) without alteration of 
its molecular weight, and this cement did not increase toxicity to pulp cells. 
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          The higher proliferative activity of Group IV (GIC +10wt% BAG) and GroupV           
(GIC +30wt % BAG) than Group I (Conventional GIC) could be explained by the fact 
that Bioglass has the ability to stimulate cell cycling and subsequently enhance 
osteoblastic turnover of human primary osteoblasts in vitro as reported by Xynos et al.
97
 
(2000). Also this was in accordance with the studies made by Bielby et al. 
5
( 2004)
 
and 
Foppiano et al. 
29 
( 2004)
 
 who stated  that bioactive glass extracts in cell culture medium 
have been shown to increase osteoblast cell proliferation. At the end of 24hrs, the 
proliferative activity of Group IV was not significantly different from control. But at     
48 hrs and 72 hrs Group IV showed higher proliferative activity than control. The 
probable reason could be less amount of BAG (10 wt %) added to GIC. With time, the 
reactivity of BAG increased resulting in release of Calcium and Phosphate ions on the 
surface that lead to increased osteoblastic proliferation. 
 
 
ALKALINE PHOSPHATASE ASSAY 
 
                 Alkaline phosphatase is an enzyme participating in bone tissue mineralization 
and an important marker of osteogenic cell differentiation
70
. ALP activity was tested at 
7,14,21 days to assess long term bioactivity of the test materials. 
 
 The results showed increased ALP activity in all groups over a period of 7, 14 
and 21 days. Throughout the observation period GroupII , Group III , Group IV, Group V 
showed higher  ALP activity than Group I (Conventional GIC) and it was statistically 
significant (p<0.05). At the end of 21days, Group II, Group III, Group IV and Group V 
showed significantly greater ALP activity than control (p<0.05). 
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          The increased ALP activity as observed in GROUP II (GIC + 10 v/v% CH), Group 
III (GIC +50v/v% CH) was in accordance with the following studies. Chitosan (CH) and  
hydroxyapatite are among the best bioactive biomaterials in bone tissue engineering and 
renowned for their excellent biocompatibility with the human body environment
90
.               
Mathews S et al. 
50
(2011) stated that  Chitosan upregulated genes associated with 
calcium binding and mineralization such as, collagen type 1 alpha 1, integrin-binding 
sialoprotein, osteopontin, osteonectin and osteocalcin, significantly.                                  
Lee SK et al.
 46
(2010)
 
found that the addition of chitosan to calcium phosphate cement 
can increase compressive strength of the cement as well as promote odontoblastic 
differentiation in human dental pulp cells. Nitra Rakkiettiwong et al.
60
 (2011)
 
devised a 
BIO-GIC(chitosan-fluoroaluminosilicate GIC with Albumin) with potential for the 
retained effect of added TGF-beta1, which was longer than the conventional GIC for its   
applications in regenerative endodontics or for use as vital pulp therapy material, which 
could promote repair of the dentin pulp complex. All these studies explains the increased 
cell differentiation potential of chitosan. 
 
            The greater alkaline phosphatase activity of Group IV (GIC +10 wt% BAG) and                         
GroupV (GIC +30wt % BAG) was in accordance with the following studies. Bosetti and 
Cannas
6 
( 2005)
 
and Lossdorfer et al.
 48
(2004) have showed that bioactive glass extracts 
in cell culture medium induce osteogenic differentiation and mineralization. Bioactive 
glass surface reaction is initiated after contact with body fluids  and subsequently, rapid 
ion exchange of Na
+
 and K
+ 
from the bioactive glass with H
+
 and H3O
+
 from the 
extracellular fluids and the network structure dissolutes, Na
+
, Ca
2+
, Mg
2+
, P
5+
 and Si
4+
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leach, and Ca
2+
 and PO4 
3+
 precipitate from the extracellular fluids onto the Si-rich 
layer
85
. Thus Bioactive glasses act as a template for osteoblast differentiation of bone 
marrow stromal cells that could be encouraged by ion exchange at the surface of the 
bioactive glass. This explains increased osteogenic potential  with addition of BAG          
( 10wt % and 30 wt %)  to GIC as found in our study.  
 
          Considering the mechanical properties on modifying GIC with Chitosan, a study 
was conducted in our department which revealed increased mean flexural strength, 
microshear bond strength for 10 v/v% Chitosan modified GIC than conventional GIC.   
While 50 v/v % Chitosan modified GIC showed increased fluoride release but poor 
mechanical properties.  
 
              Correlating the results obtained on testing mechanical properties, sealing ability 
and bioactivity,10 v/v % Chitosan modified GIC exhibited improved mean flexural 
strength, microshear  bond strength, sealing ability and bioactivity so that it could be 
suggested for use as a restorative material and also as a root end filling material. 
 
5 0 v/v % Chitosan modified GIC had compromised mechanical properties and sealing 
ability but excellent osteogenic potential. So further studies need to be conducted to 
utilize its bioactivity. 
 
                  As reported by previous studies
36,67
, addition of Bioactive Glass compromised 
the mechanical properties of GIC to some extent. In our study, improved sealing ability 
and osteogenic potential was obtained on modifying GIC with 10wt % and 30 wt% 
Bioactive Glass. This suggests the usage of GIC modified with 10 wt % or 30 wt % 
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Bioactive Glass as a root end filling where increased mechanical strength is not among 
the ideal requisite. 
 
              Within the limitations of this study it can be concluded that GIC modified with             
10 v/v % of  Chitosan and GIC with 10 wt % or 30 wt % Bioactive Glass  has improved 
sealing ability as well as osteogenic potential when compared with  conventional GIC to 
be used as a root end filling material. Further long term and in vivo studies and studies 
regarding regenerative potential could be conducted to confirm the beneficial effect of 
adding these bioactive materials. 
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SUMMARY 
The aim of this study was to evaluate the sealing ability and osteogenic potential 
of Glass ionomer cement modified with Chitosan and Bioactive glass and to compare it 
with conventional Glass ionomer cement. 
Chitosan solution was prepared and mixed with Glass ionomer liquid in 
concentration of 10 v/v% and 50 v/v % to produce Chitosan modified GIC. Similarly 
Bioactive glass was added to Glass ionomer powder in concentration of 10 wt % and     
30 wt % to produce Bioactive Glass modified GIC. 
The experimental  groups considered were 
Group I  - Conventional Glass ionomer cement 
Group II - Glass ionomer cement containing 10 v/v% Chitosan 
Group III - Glass ionomer cement containing  50 v/v% Chitosan 
Group IV   - Glass ionomer cement containing 10 wt% Bioactive Glass 
Group V - Glass ionomer cement containing  30 wt% Bioactive Glass 
SEALING ABILITY 
Dye leakage using 0.5% Rhodamine B dye and Confocal Laser Scanning 
microscopy was utilized to assess the sealing ability. Sixty freshly extracted human 
maxillary central incisors were instrumented and obturated with gutta-percha using lateral 
condensation technique & access cavities were sealed with composite. For 55 teeth 
samples, 3 mm apical root resections at 90 degrees to the long axis of the tooth was done 
and a 3 mm deep retrograde cavity was prepared with an ultrasonic tip, irrigated & dried. 
Five instrumented roots with retro-preparations received no retrograde filling, and these 
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were used as positive controls. Another five roots were instrumented and obturated with 
gutta-percha and sealer without retro preparation and their entire root surfaces were 
covered with two coats of nail polish and were used as negative controls. The teeth were 
divided into following groups: 
 
Group I  - Conventional GIC (n=10) 
Group II - GIC + 10 v/v% Chitosan (n=10) 
Group III - GIC + 50 v/v% Chitosan (n=10) 
Group IV   - GIC + 10 wt% Bioactive Glass (n=10) 
Group V - GIC +  30 wt% Bioactive Glass (n=10) 
Group VI - Positive control (n=5) 
Group VII - Negative control (n=5) 
 
The cavities were filled and specimens were stored in moist cotton at room 
temperature. Samples were coated with three coats of nail varnish except at the apical     
1 mm of the resected root, and then were allowed to dry. All the specimens were 
suspended in 0.5% Rhodamine B dye for 24 hours and rinsed for 1 hr under tap water. 
The teeth were mounted in acrylic blocks and split longitudinally with a hard tissue 
microtome using a water coolant and the specimens were examined under confocal laser 
scanning microscope at 10X magnification  and microleakage was evaluated in 
millimeters. 
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OSTEOGENIC POTENTIAL 
MTT ASSAY 
 
The SaOS-2 cells were plated in 24 well plates at a concentration of                      
3 x 10
4
 cells/well. Round-shaped samples measuring 2mm thick and 5mm in diameter (9 
for every experimental material) were prepared and rinsed three times with (PBS) and         
α-MEM medium &  placed into 24-well  plates for 24, 48  and 72 hrs and incubated at 
37º C. The medium was discarded and 100 µl of MTT containing DMEM medium was 
added to each well and  incubated for 3 hours. The MTT containing medium was then 
discarded, washed with PBS (200 µl) and the crystals were then dissolved by adding 1 ml 
of DMSO. The optical density values were measured in an ELISA reader at 545 nm. 
ALKALINE PHOSPHATASE ASSAY 
For Alkaline phosphatase assay, the test material discs were prepared & divided 
into 5 groups of 9 wells each as mentioned for MTT assay. 2×10
4
 SaOS-2 cells were 
seeded on test material discs in  osteogenic medium. Cell lysate was obtained & ALP 
activity was determined by using p-nitrophenyl phosphate as the substrate. The reaction 
was stopped by the addition of   1 N NaOH to reaction mixture and the absorbance at 405 
nm ( OD value)  was measured using auto analyser and alkaline phosphatase activity was 
expressed as μ moles of -nitrophenol / min / μg protein. 
Data were recorded and statistically analyzed using ONE WAY ANOVA and 
TUKEY HSD POST HOC multiple comparisons. 
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Considering sealing ability, Group II (GIC +10 v/v% CH), Group IV (GIC +10 
wt% BAG), GroupV (GIC +30wt % BAG) showed less linear dye penetration when 
compared with Group I (Conventional GIC). Group III (GIC +50 v/v% CH) showed 
more leakage than Group  I. 
 
Cell culture studies showed significant increase in proliferative activity in Group 
II, III, IV and V than Group I (Conventional GIC) at 24, 48 & 72 hrs. Also, there was 
increased ALP activity in Group II, III, IV and V than Group I (Conventional GIC) at 7, 
14 and 21 days of evaluation. 
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CONCLUSION 
 
From the results of this study, the following conclusions can be arrived- 
 GIC modified with 10 v/v % of Chitosan and GIC with 10 wt % or 30 wt % 
Bioactive Glass has improved sealing ability as well as osteogenic potential when 
compared with  conventional GIC to be used as a root end filling material. 
 50 v/v % Chitosan modified GIC had compromised sealing ability but excellent 
osteogenic potential. 
 Further long term and in vivo studies and studies regarding regenerative potential 
could be conducted to confirm the beneficial effect of adding these bioactive 
materials in GIC. 
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